_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
718412894,5/11/2015 12:16:23,1634036375,5/11/2015 12:16:14,false,elite,1,31856422,GBR,C9,Carlisle,92.18.171.231,[CAUSES],[CAUSES],caused by,N/A,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:27:27,1634039757,5/11/2015 12:27:17,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:29:18,1634040339,5/11/2015 12:29:02,false,prodege,1,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],caused,N/A,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:29:46,1634040458,5/11/2015 12:29:31,false,clixsense,1,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],caused by,n/a,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:34:50,1634042353,5/11/2015 12:34:23,false,neodev,1,31726043,USA,DE,"",108.59.10.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],FALCIPARUM.,vv,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:37:48,1634043350,5/11/2015 12:36:03,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:40:31,1634044233,5/11/2015 12:40:02,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],PLASMODIUM FALCIPARUM.,N/A,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:41:25,1634044572,5/11/2015 12:41:14,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused,n/a,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:42:05,1634044742,5/11/2015 12:41:08,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],MALARIA caused by PLASMODIUM FALCIPARUM.,n/a,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:42:20,1634044831,5/11/2015 12:42:06,false,elite,1,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],caused by,N/A,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:44:39,1634045581,5/11/2015 12:44:16,false,instagc,1,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",caused by,caused by,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:47:46,1634046536,5/11/2015 12:47:27,false,prodege,1,27934334,GBR,C7,Coventry,109.150.228.242,[CAUSES],[CAUSES],caused by,N/A,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:51:28,1634047632,5/11/2015 12:50:11,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],MALARIA caused by PLASMODIUM FALCIPARUM.,na,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:53:59,1634048425,5/11/2015 12:53:40,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412894,5/11/2015 12:55:58,1634049117,5/11/2015 12:54:59,false,clixsense,1,6574449,USA,NY,Lockport,69.204.2.158,[SYMPTOM],[SYMPTOM],MALARIA caused PLASMODIUM FALCIPARUM.,na,0,19,1,6,40,TWrex-cause,810964-FS1,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM
718412895,5/11/2015 14:01:48,1634072934,5/11/2015 14:01:25,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:02:42,1634073481,5/11/2015 14:02:24,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],for use,n/a,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:07:18,1634079428,5/11/2015 14:05:36,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],rifapentine can be used,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:10:26,1634086456,5/11/2015 14:09:42,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:10:28,1634086554,5/11/2015 14:10:01,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],alternative,n/a,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:10:45,1634087066,5/11/2015 14:09:47,false,points4rewards,1,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],can be used for use in conjunction with,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:11:33,1634087628,5/11/2015 14:10:48,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PULMONARY TB RIFAPENTINE is an alternative,n/a,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:14:00,1634088700,5/11/2015 14:11:09,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],used,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:19:36,1634091025,5/11/2015 14:18:15,false,bitcoinget,1,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],can be used,n/a,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 14:42:39,1634100924,5/11/2015 14:41:22,false,prodege,1,2145087,USA,NY,New York,107.107.63.225,[TREATS],[TREATS],an alternative to rifampin,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 15:29:53,1634120329,5/11/2015 15:29:14,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],rifapentine can be used in patients with noncavity PULMONARY TB,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 16:05:20,1634132610,5/11/2015 16:04:36,false,instagc,1,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],alternative for use,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 16:20:25,1634139240,5/11/2015 16:19:58,false,elite,1,30064988,GBR,H3,Leeds,92.22.160.140,[TREATS],[TREATS],use in conjunction,N/A,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 16:27:24,1634144434,5/11/2015 16:26:38,false,instagc,1,30475714,USA,OH,Salem,71.74.157.145,[TREATS],[TREATS],can be used,n/a,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412895,5/11/2015 16:45:23,1634153103,5/11/2015 16:45:03,false,clixsense,1,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,158,223,-1,169,234,TWrex-cause,800768-FS1,"14  ATS, CDC, and IDSA state that rifapentine can be used in conjunction with isoniazid in the continuation phase in HIV seronegative patients with noncavity PULMONARY TB caused by susceptible  Mycobacterium tuberculosis ; RIFAPENTINE is an alternative to rifampin for use in conjunction with isoniazid in the continuation phase.",PULMONARY TB,RIFAPENTINE
718412896,5/11/2015 10:00:50,1634000972,5/11/2015 10:00:34,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],caused,N/A,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:03:39,1634001746,5/11/2015 10:02:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Relapsing Fever Treatment of RELAPSING FEVER caused by BORRELIA RECURRENTIS.,N/A,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:12:28,1634003948,5/11/2015 10:12:11,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:21:12,1634006490,5/11/2015 10:20:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:27:24,1634008282,5/11/2015 10:26:59,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],caused,Symptom,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:32:58,1634009962,5/11/2015 10:32:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:35:25,1634010656,5/11/2015 10:34:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:45:41,1634013210,5/11/2015 10:45:21,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],caused by,N/A,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:49:03,1634013982,5/11/2015 10:48:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 10:57:34,1634016227,5/11/2015 10:57:18,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,n/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 11:21:13,1634022018,5/11/2015 11:20:56,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],Treatment,N/A,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 11:24:28,1634022598,5/11/2015 11:24:07,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[CAUSES],[CAUSES],caused by,N/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 11:29:50,1634024124,5/11/2015 11:29:39,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 11:36:46,1634025899,5/11/2015 11:36:04,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"RELAPSING FEVER caused by BORRELIA RE<span id=""transmark""></span>CURRENTIS.",n/a,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412896,5/11/2015 11:47:24,1634028360,5/11/2015 11:47:02,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[CAUSES],[CAUSES],caused by,N/A,39,66,1,53,86,TWrex-cause,812351-FS1,"d ,   e  Relapsing Fever  Treatment of RELAPSING FEVER caused by  BORRELIA RECURRENTIS.",RELAPSING FEVER,BORRELIA RECURRENTIS
718412897,5/11/2015 10:02:40,1634001476,5/11/2015 10:02:12,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],NITAZOXANIDE,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:07:54,1634002912,5/11/2015 10:06:52,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:15:59,1634005156,5/11/2015 10:15:41,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:22:22,1634006791,5/11/2015 10:22:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],clinical study,n/a,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:29:14,1634008816,5/11/2015 10:28:51,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treatment of,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:35:07,1634010611,5/11/2015 10:34:43,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],the treatment of,n/a,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:40:15,1634011814,5/11/2015 10:38:55,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:47:31,1634013609,5/11/2015 10:46:49,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],the treatment,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:52:17,1634014870,5/11/2015 10:51:10,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 10:59:25,1634016777,5/11/2015 10:58:54,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 11:23:17,1634022360,5/11/2015 11:23:03,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 11:31:16,1634024477,5/11/2015 11:31:00,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 11:39:28,1634026459,5/11/2015 11:38:35,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"NITAZOXANIDE treatment of SYMPTOMATIC GIARD<span id=""transmark""></span>IASIS",n/a,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 11:50:25,1634029081,5/11/2015 11:49:57,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],treatment of,N/A,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412897,5/11/2015 11:52:55,1634029807,5/11/2015 11:52:32,false,getpaid,1,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,125,66,-1,146,78,TWrex-cause,803520-FS1,"Ortiz JJ, Ayoub A, Gargala G, et al: Randomized clinical study of NITAZOXANIDE compared to metronidazole in the treatment of SYMPTOMATIC GIARDIASIS in children from northern Peru.",SYMPTOMATIC GIARDIASIS,NITAZOXANIDE
718412898,5/11/2015 14:00:36,1634072258,5/11/2015 14:00:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],for,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:01:13,1634072595,5/11/2015 14:00:45,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],for,n/a,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:03:21,1634073965,5/11/2015 14:02:46,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],for randomized controlled trial.,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:06:44,1634078342,5/11/2015 14:05:57,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],controlled trial.,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:07:13,1634079254,5/11/2015 14:05:50,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],vs standard interferon,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:08:46,1634082506,5/11/2015 14:07:45,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],controlled,n/a,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:09:05,1634083280,5/11/2015 14:08:23,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],for,n/a,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:09:13,1634083639,5/11/2015 14:08:39,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],RIBAVIRIN for CHRONIC HEPATITIS C,n/a,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:14:59,1634089221,5/11/2015 14:13:54,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],randomized controlled trial.,n/a,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 14:40:11,1634100057,5/11/2015 14:39:34,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.225,[TREATS],[TREATS],for,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 15:28:25,1634119727,5/11/2015 15:28:07,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],RIBAVIRIN for CHRONIC HEPATITIS C,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 15:49:15,1634126830,5/11/2015 15:48:33,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],for infected patients:,N/a,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 15:59:34,1634130339,5/11/2015 15:58:48,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],for,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 16:18:43,1634138201,5/11/2015 16:18:13,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[OTHER],[OTHER],randomized controlled trial.,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412898,5/11/2015 16:24:15,1634141966,5/11/2015 16:22:54,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[TREATS],[TREATS],plus for,N/A,117,103,-1,135,112,TWrex-cause,800135-FS1,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN
718412899,5/11/2015 12:38:37,1634043611,5/11/2015 12:38:19,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],caused by,n/a,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 12:48:35,1634046816,5/11/2015 12:48:17,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],transplacental,vdv,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 12:52:26,1634047955,5/11/2015 12:52:15,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],is caused by,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 12:57:01,1634049489,5/11/2015 12:56:31,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused by,none,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 12:59:45,1634050297,5/11/2015 12:58:37,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],transplacental acquisition,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 13:01:02,1634050697,5/11/2015 13:00:47,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],is caused by,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 13:51:10,1634068033,5/11/2015 13:50:57,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],CONGENITAL TOXOPLASMOSIS caused by acquisition of TOXOPLASMA GONDII,n/a,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 13:58:43,1634071403,5/11/2015 13:58:33,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 13:59:23,1634071736,5/11/2015 13:59:05,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused by,n/a,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 14:01:05,1634072547,5/11/2015 13:59:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 14:03:00,1634073674,5/11/2015 14:02:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 14:04:10,1634074727,5/11/2015 14:03:36,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CAUSES],[CAUSES],is caused by,N/A,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 14:06:52,1634078654,5/11/2015 14:06:29,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 14:06:55,1634078715,5/11/2015 14:06:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],CONGENITAL TOXOPLASMOSIS caused by TOXOPLASMA GONDII,n/a,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412899,5/11/2015 14:07:32,1634079877,5/11/2015 14:07:08,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SYMPTOM],[SYMPTOM],caused by,n/a,0,69,1,23,86,TWrex-cause,810695-FS1,CONGENITAL TOXOPLASMOSIS is caused by transplacental acquisition of  TOXOPLASMA GONDII,CONGENITAL TOXOPLASMOSIS,TOXOPLASMA GONDII
718412900,5/11/2015 12:31:49,1634041169,5/11/2015 12:31:39,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:35:42,1634042668,5/11/2015 12:35:17,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],in the treatment of,n/a,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:36:00,1634042788,5/11/2015 12:35:43,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],treatment,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:45:17,1634045842,5/11/2015 12:44:46,false,neodev,1.0,31726043,USA,DE,"",108.59.8.208,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],erythema,scdscc,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:49:21,1634047090,5/11/2015 12:48:56,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],in the treatment of,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:51:54,1634047779,5/11/2015 12:51:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:55:00,1634048695,5/11/2015 12:52:35,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],alTHALIDOMIDE,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 12:57:32,1634049663,5/11/2015 12:56:57,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],treatment,treated by,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 13:47:39,1634066733,5/11/2015 13:47:00,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alTHALIDOMIDE treatment of erythema nodosum leprosum in ERYTHEMA NODOSUM LEPROSUM.,n/a,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 13:52:42,1634068741,5/11/2015 13:52:09,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 13:54:54,1634069589,5/11/2015 13:53:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 13:56:46,1634070425,5/11/2015 13:55:58,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],in the treatment of,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 13:56:48,1634070441,5/11/2015 13:56:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 13:56:53,1634070536,5/11/2015 13:56:29,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412900,5/11/2015 14:02:04,1634073078,5/11/2015 14:01:47,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,149,39,-1,173,50,TWrex-cause,803403-FS1,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE
718412901,5/11/2015 09:55:06,1633999394,5/11/2015 09:53:55,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,its also a side effect,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 09:55:38,1633999541,5/11/2015 09:54:34,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",N/A,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 09:57:17,1634000081,5/11/2015 09:56:58,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[MANIFESTATION],[MANIFESTATION],initial presentation,N/A,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:07:05,1634002650,5/11/2015 10:05:16,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],however; initial presentation,n/a,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:07:07,1634002659,5/11/2015 10:06:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],THROMBOCYTOPENIC,n/a,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:10:47,1634003601,5/11/2015 10:09:21,false,prodege,1.0,20693658,USA,IL,Chicago,66.87.79.8,[MANIFESTATION],[MANIFESTATION],THROMBOCYTOPENIA THROMBOCYTOPENIC,N/A,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:18:36,1634005779,5/11/2015 10:18:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],initial presentation,n/a,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:22:50,1634006942,5/11/2015 10:22:05,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PART_OF],[PART_OF],presentation,Part of,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:24:52,1634007556,5/11/2015 10:22:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,The terms seem to describe two different things.,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:27:17,1634008256,5/11/2015 10:26:44,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],however;,two different conditions,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:34:53,1634010484,5/11/2015 10:33:42,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],THROMBOCYTOPENIC,no none,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:41:53,1634012223,5/11/2015 10:41:16,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[MANIFESTATION],[MANIFESTATION],"may occur,",N/A,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 10:52:23,1634014909,5/11/2015 10:51:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],initial presentation SLE.,n/a,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 11:15:17,1634020679,5/11/2015 11:13:17,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SYMPTOM],[SYMPTOM],presentation,N/A,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412901,5/11/2015 11:20:35,1634021790,5/11/2015 11:20:00,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[PART_OF],[PART_OF],IDIOPATHIC THROMBOCYTOPENIC PURPURA,N/a,7,44,1,22,79,TWrex-cause,814536-FS1,"Severe THROMBOCYTOPENIA may occur, however; IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) may be an initial presentation of SLE.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA
718412902,5/11/2015 14:04:39,1634075227,5/11/2015 14:04:11,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],Physical Examination Elements,N/A,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 14:05:45,1634076695,5/11/2015 14:05:22,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],Examination Elements,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 14:14:56,1634089196,5/11/2015 14:14:24,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],Elements,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 14:16:09,1634089637,5/11/2015 14:15:52,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],table,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 14:17:06,1634089994,5/11/2015 14:16:33,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[SYMPTOM],[SYMPTOM],Pyramidal signs,N/A,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 14:18:01,1634090352,5/11/2015 14:17:22,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],signs such as SENSORY for MS,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 14:42:55,1634101006,5/11/2015 14:41:20,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[SYMPTOM],[SYMPTOM],signs such as,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 15:34:38,1634121965,5/11/2015 15:34:17,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],SENSORY LOSS Elements for MS,N/A,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 16:11:54,1634135206,5/11/2015 16:11:22,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[SYMPTOM],[SYMPTOM],signs,N/A,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 16:26:14,1634143548,5/11/2015 16:25:47,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[SYMPTOM],[SYMPTOM],Pyramidal signs,N/A,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 16:33:21,1634147270,5/11/2015 16:32:30,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[SYMPTOM],[SYMPTOM],signs,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 16:48:04,1634154697,5/11/2015 16:47:43,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 17:22:28,1634171989,5/11/2015 17:22:10,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",See table History and Physical Examination Elements for MS,n/a,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 17:35:16,1634191399,5/11/2015 17:34:51,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],signs,symptoms,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412902,5/11/2015 17:36:23,1634193693,5/11/2015 17:35:41,false,instagc,1,20312760,GBR,I2,Manchester,90.244.159.123,[SYMPTOM],[SYMPTOM],SENSORY LOSS Physical Examination Elements for MS,N/A,70,264,1,81,266,TWrex-cause,813602-FS1,"◊ Pyramidal signs such as hyperreflexia, spasticity, Babinski signs ◊ SENSORY LOSS especially sensory level and impaired vibratory and proprioceptive sensation in limbs ◊ Ataxia of gait and limb movements • See table  History and Physical Examination Elements for MS",SENSORY LOSS,MS
718412903,5/11/2015 10:13:26,1634004241,5/11/2015 10:13:07,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],attribute,N/A,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:27:20,1634008262,5/11/2015 10:26:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],"more perceived disability,",n/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:28:27,1634008561,5/11/2015 10:27:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",N/A,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:35:19,1634010647,5/11/2015 10:34:07,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],"perceived disability,",n/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:44:08,1634012818,5/11/2015 10:43:22,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],more,Side effect,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:48:17,1634013836,5/11/2015 10:47:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],have more,n/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:54:37,1634015441,5/11/2015 10:52:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],attribute perceived,N/A,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 10:59:38,1634016799,5/11/2015 10:59:08,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],have more PAIN,n/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 11:18:44,1634021359,5/11/2015 11:17:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",more self reported PAIN,n/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 11:34:23,1634025259,5/11/2015 11:33:27,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],attribute,N/A,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 11:38:41,1634026340,5/11/2015 11:38:28,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 11:54:17,1634030109,5/11/2015 11:53:33,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"attribute FM to PAIN<span id=""transmark""></span>",n/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 12:05:43,1634033231,5/11/2015 12:05:23,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[MANIFESTATION],[MANIFESTATION],have more,N/A,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 12:12:17,1634035131,5/11/2015 12:11:31,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[ASSOCIATED_WITH],[ASSOCIATED_WITH],have more self reported,N/a,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412903,5/11/2015 12:23:39,1634038617,5/11/2015 12:22:57,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[SYMPTOM],[SYMPTOM],reported,N/A,126,67,1,129,69,TWrex-cause,812634-FS1,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM
718412904,5/11/2015 12:30:22,1634040688,5/11/2015 12:30:08,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],using,n/a,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:33:35,1634041859,5/11/2015 12:33:06,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],recoveries of using,n/a,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:33:58,1634042071,5/11/2015 12:33:18,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:42:24,1634044833,5/11/2015 12:42:13,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[CAUSES],[CAUSES],Comparison,dfdf,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:46:23,1634046139,5/11/2015 12:45:49,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:47:58,1634046640,5/11/2015 12:46:29,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],recoveries,none,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:49:46,1634047220,5/11/2015 12:49:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],recoveries MYCOBACTERIUM TUBERCULOSIS BACTEC 460 TB SYSTEM,n/a,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:50:02,1634047282,5/11/2015 12:49:09,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],MYCOBACTERIUM TUBERCULOSIS,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 12:55:12,1634048791,5/11/2015 12:54:26,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[OTHER] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]",using the,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 13:46:00,1634066201,5/11/2015 13:43:05,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],recoveries,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 13:50:51,1634067908,5/11/2015 13:49:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],recoveries of,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 13:51:10,1634068039,5/11/2015 13:49:10,false,instagc,1,29444531,USA,GA,Conyers,184.37.250.198,[OTHER],[OTHER],Comparison,comparison,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 13:51:23,1634068165,5/11/2015 13:50:09,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Comparison of,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 13:55:05,1634069665,5/11/2015 13:54:18,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Comparison of recoveries of using the,N/A,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412904,5/11/2015 13:55:08,1634069680,5/11/2015 13:54:27,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,n/a,176,101,1,195,127,TWrex-cause,810857-FS1,"3]  Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of MYCOBACTERIUM TUBERCULOSIS using the automated BACTEC MGIT 960 system, the BACTEC 460 TB SYSTEM and Lowenstein Jensen medium.",BACTEC 460 TB SYSTEM,MYCOBACTERIUM TUBERCULOSIS
718412905,5/11/2015 12:37:24,1634043174,5/11/2015 12:36:45,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CONTRAINDICATES],[CONTRAINDICATES],ineffective the management of,n/a,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 12:47:05,1634046328,5/11/2015 12:46:49,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],caused,cdcdf,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 12:50:53,1634047482,5/11/2015 12:50:39,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],caused by,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 12:54:26,1634048543,5/11/2015 12:54:00,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 12:57:09,1634049513,5/11/2015 12:56:28,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],PHEOCHROMOCYTOMA,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 13:00:02,1634050381,5/11/2015 12:59:47,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],caused by,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 13:49:35,1634067427,5/11/2015 13:49:20,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],HYPERTENSION caused by PHEOCHROMOCYTOMA,n/a,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 13:57:48,1634070906,5/11/2015 13:57:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused by,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 13:58:07,1634071058,5/11/2015 13:56:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 13:58:20,1634071141,5/11/2015 13:58:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused by,n/a,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 13:59:22,1634071731,5/11/2015 13:58:54,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 14:00:18,1634072091,5/11/2015 13:59:33,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diazoxide is ineffective,N/A,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 14:04:06,1634074635,5/11/2015 14:03:35,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 14:05:16,1634075978,5/11/2015 14:04:24,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SIDE_EFFECT],[SIDE_EFFECT],caused by,n/a,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412905,5/11/2015 14:05:16,1634075989,5/11/2015 14:04:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],HYPERTENSION caused by PHEOCHROMOCYTOMA,n/a,49,72,1,60,88,TWrex-cause,813053-FS1,b  Diazoxide is ineffective in the management of HYPERTENSION caused by PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA
718412906,5/11/2015 12:29:35,1634040432,5/11/2015 12:29:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],may produce,n/a,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:32:21,1634041397,5/11/2015 12:32:02,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],simulating,n/a,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:32:39,1634041468,5/11/2015 12:32:17,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],produce,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:40:34,1634044248,5/11/2015 12:39:07,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],ADRENAL,dsx,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:43:28,1634045272,5/11/2015 12:43:13,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[OTHER],[OTHER],simulating,simulate,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:45:05,1634045754,5/11/2015 12:42:57,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,SPONTANEOUS ADRENAL HEMORRHAGE  may produce  NEUROBLASTOMA,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:45:06,1634045756,5/11/2015 12:44:30,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],simulating,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:47:47,1634046542,5/11/2015 12:45:33,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],HEMORRHAGE,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:48:10,1634046699,5/11/2015 12:47:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[MANIFESTATION],[MANIFESTATION],SPONTANEOUS ADRENAL HEMORRHAGE may produce NEUROBLASTOMA,na,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 12:52:22,1634047937,5/11/2015 12:51:08,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES],[CAUSES],simulating,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 13:41:57,1634064817,5/11/2015 13:40:30,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],produce,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 13:47:52,1634066817,5/11/2015 13:46:48,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],produce,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 13:48:03,1634066907,5/11/2015 13:47:31,false,instagc,1.0,29444531,USA,GA,Conyers,184.37.250.198,[CAUSES],[CAUSES],may produce,NA,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 13:48:08,1634066930,5/11/2015 13:47:15,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CAUSES],[CAUSES],may produce,N/A,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412906,5/11/2015 13:54:01,1634069284,5/11/2015 13:53:20,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],produce,n/a,28,104,1,57,117,TWrex-cause,814144-FS1,"Less commonly, in newborns, SPONTANEOUS ADRENAL HEMORRHAGE may produce large adrenal masses, simulating NEUROBLASTOMA or Wilms' tumor.",SPONTANEOUS ADRENAL HEMORRHAGE,NEUROBLASTOMA
718412907,5/11/2015 12:31:38,1634041100,5/11/2015 12:31:25,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:35:16,1634042502,5/11/2015 12:34:57,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment of,n/a,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:35:42,1634042667,5/11/2015 12:35:24,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],treatment,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:44:41,1634045605,5/11/2015 12:44:15,false,neodev,1.0,31726043,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],ranitidine,ds,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:48:55,1634046951,5/11/2015 12:48:38,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],treatment of,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:51:10,1634047579,5/11/2015 12:50:24,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,other,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:52:34,1634047967,5/11/2015 12:51:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],REFLUX ESOPHAGITIS,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 12:56:56,1634049469,5/11/2015 12:56:44,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],treatment,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 13:46:59,1634066485,5/11/2015 13:46:32,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alOMEPRAZOLE treatment of REFLUX ESOPHAGITIS,n/a,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 13:52:08,1634068489,5/11/2015 13:51:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 13:53:52,1634069249,5/11/2015 13:53:32,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 13:55:52,1634070026,5/11/2015 13:55:04,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],long term treatment,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 13:56:28,1634070295,5/11/2015 13:56:02,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 13:56:30,1634070297,5/11/2015 13:56:14,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412907,5/11/2015 14:01:45,1634072928,5/11/2015 14:01:20,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,88,37,-1,105,47,TWrex-cause,804104-FS1,"Hallerback B, Unge P, Carling L et alOMEPRAZOLE or ranitidine in long term treatment of REFLUX ESOPHAGITIS",REFLUX ESOPHAGITIS,OMEPRAZOLE
718412908,5/11/2015 14:05:52,1634076867,5/11/2015 14:05:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 14:07:05,1634078989,5/11/2015 14:06:41,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],diagnostic features,n/a,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 14:17:36,1634090249,5/11/2015 14:17:00,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic features,n/a,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 14:20:58,1634091723,5/11/2015 14:20:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],CAFÉ AU LAIT SPOTS diagnostic features of NEUROFIBROMATOSIS TYPE I.,n/a,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 14:46:00,1634102302,5/11/2015 14:44:33,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic features,n/a,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 15:35:49,1634122460,5/11/2015 15:35:27,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],having CAFÉ AU LAIT SPOTS are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 16:27:47,1634144713,5/11/2015 16:27:17,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[CAUSES],[CAUSES],cardinal diagnostic features,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 16:34:59,1634147856,5/11/2015 16:34:29,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[SYMPTOM],[SYMPTOM],diagnostic features,n/a,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 16:48:45,1634154927,5/11/2015 16:48:36,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 17:23:34,1634173249,5/11/2015 17:23:25,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","diameter before puberty,",n/a,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 17:37:07,1634195006,5/11/2015 17:36:37,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],having six or more,symptom,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 17:39:11,1634199195,5/11/2015 17:38:24,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[SYMPTOM],[SYMPTOM],CAFÉ AU LAIT SPOTS features of NEUROFIBROMATOSIS TYPE I.,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 17:45:26,1634213137,5/11/2015 17:45:11,false,instagc,1,23035364,USA,NJ,Blackwood,50.153.127.6,[TREATS],[TREATS],having,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 17:54:24,1634235459,5/11/2015 17:53:52,false,gptking,1,31799065,USA,IL,Marion,50.45.43.154,[SYMPTOM],[SYMPTOM],CAFÉ AU LAIT SPOTS NEUROFIBROMATOSIS TYPE I.,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412908,5/11/2015 18:33:12,1634271519,5/11/2015 18:32:05,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",diagnostic features,N/A,33,183,1,50,207,TWrex-cause,812642-FS1,"Specifically, having six or more CAFÉ AU LAIT SPOTS greater than 5 mm in diameter before puberty, or greater than 15 mm in diameter after puberty, are cardinal diagnostic features of NEUROFIBROMATOSIS TYPE I.",CAFÉ AU LAIT SPOTS,NEUROFIBROMATOSIS TYPE I
718412909,5/11/2015 12:29:18,1634040338,5/11/2015 12:28:47,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],with,n/a,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:32:01,1634041259,5/11/2015 12:31:37,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],in treating,n/a,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:32:14,1634041378,5/11/2015 12:31:55,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],treating,N/A,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:38:58,1634043762,5/11/2015 12:38:41,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[CAUSES],[CAUSES],receptor,cxzc,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:42:57,1634045129,5/11/2015 12:42:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treating,none,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:43:12,1634045146,5/11/2015 12:43:02,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treating,n/a,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:44:29,1634045495,5/11/2015 12:44:09,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],treating patients with,N/A,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:45:31,1634045913,5/11/2015 12:44:34,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],alOMEPRAZOLE,N/A,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:47:12,1634046390,5/11/2015 12:46:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alOMEPRAZOLE treating patients with ESOPHAGITIS,n/a,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:50:14,1634047325,5/11/2015 12:49:51,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],in treating,N/A,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 12:51:06,1634047524,5/11/2015 12:50:22,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",treating,treaTED BY,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 13:40:29,1634064436,5/11/2015 13:39:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treating,N/A,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 13:46:47,1634066418,5/11/2015 13:46:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],in treating,N/A,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 13:47:30,1634066660,5/11/2015 13:47:04,false,instagc,1.0,29444531,USA,GA,Conyers,184.37.250.198,[TREATS],[TREATS],treating,NA,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412909,5/11/2015 13:48:16,1634066961,5/11/2015 13:47:29,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],treating patients,n/a,124,35,-1,134,45,TWrex-cause,803811-FS1,"Marks RD, Richter JE, Rizzo J et alOMEPRAZOLE versus H2 receptor antagonists in treating patients with peptic stricture and ESOPHAGITIS",ESOPHAGITIS,OMEPRAZOLE
718412910,5/11/2015 10:01:42,1634001208,5/11/2015 10:01:24,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[SYMPTOM],[SYMPTOM],another common feature,N/A,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:05:37,1634002309,5/11/2015 10:04:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,N/A,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:14:47,1634004678,5/11/2015 10:13:43,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],common feature of,n/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:21:47,1634006610,5/11/2015 10:21:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],common feature,n/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:28:18,1634008520,5/11/2015 10:27:54,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],feature,Symptom,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:34:17,1634010327,5/11/2015 10:33:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],common feature of,n/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:38:12,1634011341,5/11/2015 10:36:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],common feature of,N/A,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:46:22,1634013328,5/11/2015 10:46:03,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[MANIFESTATION],[MANIFESTATION],common feature,N/A,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:50:46,1634014488,5/11/2015 10:50:27,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],common feature of,n/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 10:58:24,1634016443,5/11/2015 10:58:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],common feature,n/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 11:22:29,1634022258,5/11/2015 11:21:59,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[SYMPTOM],[SYMPTOM],feature,N/A,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 11:25:14,1634022820,5/11/2015 11:24:53,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[SYMPTOM],[SYMPTOM],feature of,N/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 11:30:24,1634024257,5/11/2015 11:30:08,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",no,no,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 11:37:46,1634026187,5/11/2015 11:37:18,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[SYMPTOM],[SYMPTOM],"CHRONIC DIARRHEA feature of ETHYLMALONIC EN<span id=""transmark""></span>CEPHALOPATHY",n/a,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412910,5/11/2015 11:48:45,1634028746,5/11/2015 11:48:14,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[SYMPTOM],[SYMPTOM],common feature,N/A,0,46,1,15,73,TWrex-cause,812888-FS1,CHRONIC DIARRHEA is another common feature of ETHYLMALONIC ENCEPHALOPATHY,CHRONIC DIARRHEA,ETHYLMALONIC ENCEPHALOPATHY
718412911,5/11/2015 12:31:24,1634040988,5/11/2015 12:30:59,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:34:56,1634042411,5/11/2015 12:34:35,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[SYMPTOM],[SYMPTOM],suggest,n/a,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:35:23,1634042523,5/11/2015 12:34:55,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],suggest,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:44:08,1634045392,5/11/2015 12:43:41,false,neodev,1.0,31726043,USA,DE,"",108.59.8.208,[LOCATION],[LOCATION],bowel,dsds,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:48:37,1634046817,5/11/2015 12:48:02,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[MANIFESTATION] [ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",suggest,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:50:22,1634047359,5/11/2015 12:49:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],suggest,none,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:51:47,1634047739,5/11/2015 12:51:28,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],COLITIS CROHN'S,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 12:56:42,1634049416,5/11/2015 12:56:21,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],suggest,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:46:31,1634066341,5/11/2015 13:46:01,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],BLOODY DIARRHEA suggest (ULCERATIVE COLITIS CROHN'S DISEASE,n/a,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:51:19,1634068139,5/11/2015 13:49:27,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],suggest,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:53:31,1634069112,5/11/2015 13:52:40,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],suggest,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:54:51,1634069562,5/11/2015 13:53:35,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[MANIFESTATION],[MANIFESTATION],suggest inflammatory bowel disease,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:56:01,1634070113,5/11/2015 13:55:38,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],suggest,n/a,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:56:13,1634070197,5/11/2015 13:55:48,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggest,N/A,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412911,5/11/2015 13:56:46,1634070422,5/11/2015 13:56:12,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],suggest,n/a,0,77,1,14,112,TWrex-cause,812921-FS1,"BLOODY DIARRHEA fever, and abdominal pain suggest inflammatory bowel disease (ULCERATIVE COLITIS CROHN'S DISEASE or an infectious colitis (eg,  Shigella,Salmonella,Campylobacter,  amebiasis.",BLOODY DIARRHEA,(ULCERATIVE COLITIS CROHN'S DISEASE
718412912,5/11/2015 09:56:28,1633999818,5/11/2015 09:55:36,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,get rid of headache before treating cluster headache,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 09:58:20,1634000325,5/11/2015 09:57:47,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS],[PREVENTS],prevent,N/A,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 09:58:43,1634000388,5/11/2015 09:56:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[IS_A],[IS_A],COMMENTARY Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,N/A,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:07:49,1634002886,5/11/2015 10:07:30,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],HEADACHES,n/a,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:09:05,1634003168,5/11/2015 10:07:52,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],prevent,n/a,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:11:59,1634003868,5/11/2015 10:11:17,false,prodege,1.0,20693658,USA,IL,Chicago,66.87.79.8,[IS_A],[IS_A],HEADACHE HEADACHES,N/A,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:19:23,1634006003,5/11/2015 10:18:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prevent,n/a,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:24:09,1634007321,5/11/2015 10:23:16,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],includes,Associated with,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:28:03,1634008444,5/11/2015 10:25:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,"They are related, but the relation is not present in the sentence.",108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:28:35,1634008583,5/11/2015 10:27:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],CLUSTER HEADACHE,n/a,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:36:40,1634010942,5/11/2015 10:35:57,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],prevent,no none,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:43:01,1634012563,5/11/2015 10:42:31,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[IS_A],[IS_A],current headache,N/A,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 10:54:12,1634015325,5/11/2015 10:52:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],prevent HEADACHES,n/a,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 11:17:18,1634021058,5/11/2015 11:16:21,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS] [PART_OF],"[PREVENTS]
[PART_OF]",includes,N/A,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412912,5/11/2015 11:21:48,1634022138,5/11/2015 11:21:07,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[IS_A],[IS_A],HEADACHE HEADACHES,N/a,108,25,1,116,41,TWrex-cause,814704-FS1,COMMENTARY  Treatment of CLUSTER HEADACHE includes aborting any current headache and prophylaxis to prevent HEADACHES both during the current cluster and in future clusters.,HEADACHES,CLUSTER HEADACHE
718412913,5/11/2015 10:01:23,1634001139,5/11/2015 10:00:51,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS],[PREVENTS],"safety, efficacy compliance",N/A,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:04:48,1634002064,5/11/2015 10:03:40,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",N/A,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:13:42,1634004322,5/11/2015 10:12:29,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],efficacy and compliance,n/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:21:27,1634006576,5/11/2015 10:21:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:27:53,1634008405,5/11/2015 10:27:26,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],for,Treated by,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:33:52,1634010215,5/11/2015 10:32:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],THERAPY for,n/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:36:21,1634010854,5/11/2015 10:35:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:46:02,1634013291,5/11/2015 10:45:42,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],THERAPY for,N/A,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:50:25,1634014449,5/11/2015 10:49:04,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],THERAPY for,n/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 10:58:04,1634016346,5/11/2015 10:57:35,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],THERAPY,n/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 11:21:58,1634022185,5/11/2015 11:21:14,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],"safety,",N/A,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 11:24:51,1634022675,5/11/2015 11:24:29,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],THERAPY for,N/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 11:30:06,1634024198,5/11/2015 11:29:51,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[SYMPTOM] [CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 11:37:17,1634026020,5/11/2015 11:36:48,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"TERAZOSIN THERAPY for BENIGN PROSTATIC HYP<span id=""transmark""></span>ERPLASIA",n/a,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412913,5/11/2015 11:48:12,1634028567,5/11/2015 11:47:24,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],THERAPY for,N/A,61,39,-1,88,56,TWrex-cause,804592-FS1,"The safety, efficacy and compliance of TERAZOSIN THERAPY for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN THERAPY
718412914,5/11/2015 12:15:59,1634036273,5/11/2015 12:15:45,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:26:56,1634039666,5/11/2015 12:26:36,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],of,n/a,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:28:38,1634040214,5/11/2015 12:27:38,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],and,N/A,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:29:02,1634040304,5/11/2015 12:28:39,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],mechanisms of,n/a,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:33:45,1634041998,5/11/2015 12:33:29,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[PREVENTS],[PREVENTS],PELVIC,vv,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:34:53,1634042369,5/11/2015 12:34:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],mechanisms,none,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:39:38,1634043925,5/11/2015 12:39:18,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],PELVIC PAIN,N/A,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:40:39,1634044286,5/11/2015 12:39:34,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],ENDOMETRIOSIS and mechanisms of PELVIC PAIN,n/a,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:41:01,1634044439,5/11/2015 12:40:32,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],and,n/a,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:41:38,1634044639,5/11/2015 12:40:54,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[NONE],[NONE],N/A,Unclear if any relation exists.,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:43:53,1634045341,5/11/2015 12:42:07,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],of,N/A,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:47:05,1634046324,5/11/2015 12:46:07,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[SYMPTOM],[SYMPTOM],mechanisms of,N/A,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:49:32,1634047133,5/11/2015 12:48:14,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[NONE],[NONE],na,It does not go into any details about this and what it does,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:53:12,1634048121,5/11/2015 12:52:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],mechanisms of,N/A,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412914,5/11/2015 12:54:03,1634048433,5/11/2015 12:53:11,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],ENDOMETRIOSIS mechanisms PELVIC PAIN,na,32,0,1,42,13,TWrex-cause,814030-FS1,ENDOMETRIOSIS and mechanisms of PELVIC PAIN,PELVIC PAIN,ENDOMETRIOSIS
718412915,5/11/2015 11:39:11,1634026405,5/11/2015 11:38:58,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 11:55:36,1634030448,5/11/2015 11:54:53,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[IS_A],[IS_A],"WARFARIN in WARFA<span id=""transmark""></span>RIN",n/a,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:06:21,1634033389,5/11/2015 12:05:59,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],in elderly patients,N/A,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:13:13,1634035379,5/11/2015 12:12:43,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PART_OF],[PART_OF],WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN WARFARIN,N/a,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:24:08,1634038771,5/11/2015 12:23:40,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],REDUCED,N/A,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:24:27,1634038837,5/11/2015 12:23:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Keywords:,n/a,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:25:38,1634039195,5/11/2015 12:24:49,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],REDUCED MAJOR STROKE,n/a,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:26:43,1634039594,5/11/2015 12:24:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,How warfarin was better than aspirin for  reducing strokes was already stated,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:31:01,1634040849,5/11/2015 12:30:43,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],THAN,rrvg,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:32:11,1634041325,5/11/2015 12:31:41,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[PREVENTS],[PREVENTS],Practitioner Cardiology,N/A,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:34:46,1634042337,5/11/2015 12:33:54,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PART_OF],[PART_OF],WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN WARFARIN,n/a,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:37:13,1634043126,5/11/2015 12:34:54,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[NONE] [PART_OF],"[PART_OF]
[NONE]",N/A,The second term is part of the first one.,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:38:46,1634043663,5/11/2015 12:37:47,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],REDUCED,n/a,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:39:15,1634043840,5/11/2015 12:38:38,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[NONE],[NONE],N/A,Warfarin is in the longer term,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412915,5/11/2015 12:42:36,1634044904,5/11/2015 12:41:00,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[OTHER],[OTHER],REDUCED STROKE MORE THAN,N/A,0,0,-1,46,8,TWrex-cause,803780-FS1,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN in elderly patients with atrial fibrillation in primary care  General Internal Medicine/Family Practitioner/General Practitioner Cardiology Geriatrics Hematology/Thrombosis Neurology  About Star Ratings  Keywords: Atrial fibrillation WARFARIN Anticoagulants Aspirin.,WARFARIN REDUCED MAJOR STROKE MORE THAN ASPIRIN,WARFARIN
718412916,5/11/2015 12:29:54,1634040503,5/11/2015 12:29:36,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causes,n/a,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:32:46,1634041526,5/11/2015 12:32:22,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],causes,n/a,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:32:58,1634041586,5/11/2015 12:32:41,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],causes,N/A,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:41:23,1634044564,5/11/2015 12:40:42,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.77.4,[LOCATION],[LOCATION],DISEASE,dxc,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:43:52,1634045340,5/11/2015 12:43:29,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],causes,n/a,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:45:32,1634045920,5/11/2015 12:45:07,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],causes,N/A,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:45:51,1634046046,5/11/2015 12:45:06,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causes,none,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:48:43,1634046856,5/11/2015 12:47:48,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],MELIOIDOSIS,N/A,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:49:01,1634046962,5/11/2015 12:48:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],BURKHOLDERIA PSEUDOMALLEI causes DISEASE KNOWN AS MELIOIDOSIS,n/a,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 12:53:36,1634048333,5/11/2015 12:52:24,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",causes,caused by,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 13:42:42,1634065032,5/11/2015 13:41:58,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],causes,N/A,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 13:48:21,1634066975,5/11/2015 13:48:05,false,instagc,1.0,29444531,USA,GA,Conyers,184.37.250.198,[CAUSES],[CAUSES],causes,NA,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 13:49:16,1634067316,5/11/2015 13:47:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],causes,N/A,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 13:49:20,1634067342,5/11/2015 13:48:19,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CAUSES],[CAUSES],causes,N/A,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412916,5/11/2015 13:53:19,1634069007,5/11/2015 13:50:40,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],causes,n/a,45,0,1,87,25,TWrex-cause,812253-FS1,BURKHOLDERIA PSEUDOMALLEI  causes a distinct DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY limited to the Asian tropics (see  Melioidosis.,DISEASE KNOWN AS MELIOIDOSIS THAT IS MOSTLY,BURKHOLDERIA PSEUDOMALLEI
718412917,5/11/2015 10:02:10,1634001364,5/11/2015 10:01:43,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],initial treatment,N/A,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:06:51,1634002569,5/11/2015 10:05:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PART_OF],[PART_OF],not be used for initial treatment of HYPERTENSION,N/A,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:15:41,1634005014,5/11/2015 10:14:48,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],not be used for initial treatment,n/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:22:08,1634006751,5/11/2015 10:21:48,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Dosage Administration,n/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:28:50,1634008644,5/11/2015 10:28:19,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CONTRAINDICATES],[CONTRAINDICATES],not,Do not use for,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:34:42,1634010442,5/11/2015 10:34:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],should not be used for treatment of,n/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:38:52,1634011568,5/11/2015 10:38:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CONTRAINDICATES],[CONTRAINDICATES],should not be used for,N/A,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:46:48,1634013412,5/11/2015 10:46:23,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CONTRAINDICATES],[CONTRAINDICATES],should not be used,N/A,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:51:09,1634014567,5/11/2015 10:50:47,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],should not be used for,n/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 10:58:53,1634016617,5/11/2015 10:58:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],used for initial treatment,n/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 11:23:02,1634022315,5/11/2015 11:22:31,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CONTRAINDICATES],[CONTRAINDICATES],not be used,N/A,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 11:30:58,1634024386,5/11/2015 11:30:27,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 11:38:34,1634026321,5/11/2015 11:37:47,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[OTHER],[OTHER],"LISINOPRIL/hydrochlorothiazide not be used for treatment of HYPERTENSIO<span id=""transmark""></span>N",n/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 11:49:55,1634028975,5/11/2015 11:48:47,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[OTHER],[OTHER],not used for initial treatment,N/A,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412917,5/11/2015 11:52:31,1634029717,5/11/2015 11:51:47,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,158,64,-1,169,75,TWrex-cause,804115-FS1,"59 ,   60  Dosage and Administration  General  Hypertension  •  LISINOPRIL/hydrochlorothiazide fixed combinations should not be used for initial treatment of HYPERTENSION",HYPERTENSION,LISINOPRIL/
718412918,5/11/2015 14:03:49,1634074401,5/11/2015 14:03:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 14:05:07,1634075791,5/11/2015 14:04:48,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 14:13:48,1634088605,5/11/2015 14:12:50,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],no longer,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 14:15:28,1634089381,5/11/2015 14:14:49,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],treatment,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 14:15:35,1634089455,5/11/2015 14:14:39,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CONTRAINDICATES],[CONTRAINDICATES],evidence suggests no mortality benefit.,N/A,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 14:16:38,1634089810,5/11/2015 14:15:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],PRAZOSIN no longer used for treatment of HYPERTENSION,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 14:40:20,1634100132,5/11/2015 14:39:44,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],treatment,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 15:33:59,1634121762,5/11/2015 15:32:44,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],PRAZOSIN no longer used for primary treatment of HYPERTENSION,N/A,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 16:09:56,1634134358,5/11/2015 16:08:49,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],treatment,N/A,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 16:24:44,1634142337,5/11/2015 16:24:07,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[OTHER],[OTHER],no longer used for primary treatment,N/A,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 16:31:44,1634146578,5/11/2015 16:31:04,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[TREATS],[TREATS],treatment of,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 16:47:22,1634154401,5/11/2015 16:47:11,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 17:21:50,1634171499,5/11/2015 17:21:31,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],are no longer used for primary treatment,n/a,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 17:34:23,1634189765,5/11/2015 17:34:03,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],primary treatment of,it treats hypertension,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412918,5/11/2015 17:35:03,1634190911,5/11/2015 17:34:14,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CONTRAINDICATES],[CONTRAINDICATES],PRAZOSIN no longer treatment HYPERTENSION,N/A,107,32,-1,118,40,TWrex-cause,803785-FS1,"Postsynaptic α 1  blockers (eg, PRAZOSIN terazosin, doxazosin) are no longer used for primary treatment of HYPERTENSION because evidence suggests no mortality benefit.",HYPERTENSION,PRAZOSIN
718412919,5/11/2015 09:59:12,1634000606,5/11/2015 09:58:42,false,prodege,1,14528761,GBR,V2,Glasgow,2.222.244.231,[SYMPTOM],[SYMPTOM],characteristics,N/A,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:01:02,1634001014,5/11/2015 09:59:40,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [CAUSES],"[CAUSES]
[SIDE_EFFECT]","The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",N/A,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:08:53,1634003156,5/11/2015 10:08:12,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[NONE],[NONE],N/A,must be differentiated from,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:10:03,1634003357,5/11/2015 10:09:27,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],differentiated,n/a,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:20:03,1634006155,5/11/2015 10:19:39,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],differentiated,n/a,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:25:54,1634007821,5/11/2015 10:24:40,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[NONE],[NONE],NA,No relation,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:30:22,1634009159,5/11/2015 10:29:04,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,two different ailments,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:30:42,1634009334,5/11/2015 10:29:03,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],differentiated from,N/A,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:38:27,1634011420,5/11/2015 10:37:40,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[CONTRAINDICATES],[CONTRAINDICATES],differentiated,no none,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:44:09,1634012819,5/11/2015 10:43:24,false,prodege,1,14848125,GBR,L6,Shrewsbury,86.138.223.142,[OTHER],[OTHER],differentiated from,N/A,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 10:56:13,1634015866,5/11/2015 10:54:35,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[OTHER],[OTHER],differentiated from,is different to,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 11:19:58,1634021625,5/11/2015 11:18:53,false,neodev,1,20961587,NLD,05,Maastricht,84.26.48.136,[SIDE_EFFECT],[SIDE_EFFECT],differentiated,N/A,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 11:23:08,1634022346,5/11/2015 11:22:11,false,prodege,1,22031444,GBR,K6,Portsmouth,89.240.160.95,[NONE],[NONE],N/a,Two separate unrelated things.,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 11:29:05,1634023907,5/11/2015 11:28:49,false,neodev,1,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412919,5/11/2015 11:32:33,1634024788,5/11/2015 11:31:32,false,clixsense,1,22947672,GBR,"","",88.144.86.217,[OTHER],[OTHER],"TN be differentiated from MASTICATORY PAI<span id=""transmark""></span>N",I have not,209,61,1,224,63,TWrex-cause,812652-FS1,"The dentist must ensure a correct diagnosis does not mistake TN as a temporomandibular disorder.[17] Since triggering may be caused by movements of the tongue or facial muscles, TN must be differentiated from MASTICATORY PAIN that has the clinical characteristics of deep somatic rather than neuropathic pain.",MASTICATORY PAIN,TN
718412920,5/11/2015 10:12:29,1634003950,5/11/2015 10:11:59,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],*Triple drug therapy,N/A,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:24:18,1634007397,5/11/2015 10:22:47,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is &gt; 4 mg/mL.",N/A,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:26:26,1634007977,5/11/2015 10:26:12,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],drug therapy,n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:32:59,1634009958,5/11/2015 10:32:05,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],necessary for,n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:42:25,1634012423,5/11/2015 10:41:58,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],therapy,Treatment of,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:46:34,1634013370,5/11/2015 10:45:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],drug therapy may be necessary,n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:51:20,1634014619,5/11/2015 10:50:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],drug therapy,N/A,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 10:58:15,1634016392,5/11/2015 10:57:56,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],drug therapy with,n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 11:16:32,1634020926,5/11/2015 11:16:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 11:32:40,1634024837,5/11/2015 11:32:25,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],therapy,N/A,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 11:37:56,1634026209,5/11/2015 11:37:43,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 11:52:10,1634029608,5/11/2015 11:50:48,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"therapy with VANCOMYCIN for PNEUMOCOCCAL MENI<span id=""transmark""></span>NGITIS",n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 12:02:11,1634032231,5/11/2015 12:00:05,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],may be necessary for,N/A,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 12:10:25,1634034562,5/11/2015 12:09:44,false,getpaid,1,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],therapy may be necessary,N/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412920,5/11/2015 12:22:45,1634038373,5/11/2015 12:22:23,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],drug therapy,n/a,105,26,-1,127,36,TWrex-cause,805206-FS1,"*Triple drug therapy with VANCOMYCIN rifampin, and either ceftriaxone or cefotaxime may be necessary for PNEUMOCOCCAL MENINGITIS if the minimum inhibitory concentration of either cephalosporin is > 4 mg/mL.",PNEUMOCOCCAL MENINGITIS,VANCOMYCIN
718412921,5/11/2015 10:07:32,1634002833,5/11/2015 10:07:04,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggest,N/A,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:18:25,1634005744,5/11/2015 10:17:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",N/A,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:25:02,1634007581,5/11/2015 10:24:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],strongly suggest,n/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:29:56,1634009033,5/11/2015 10:28:24,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],strongly suggest,n/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:35:09,1634010628,5/11/2015 10:34:29,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],suggest,Suggests,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:43:48,1634012717,5/11/2015 10:42:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],strongly suggest,n/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:47:59,1634013779,5/11/2015 10:47:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",strongly suggest,N/A,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 10:56:12,1634015865,5/11/2015 10:55:52,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],strongly suggest,n/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:14:04,1634020297,5/11/2015 11:13:41,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],strongly suggest,n/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:31:06,1634024416,5/11/2015 11:30:22,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],suggest,N/A,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:34:34,1634025318,5/11/2015 11:33:17,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:48:10,1634028568,5/11/2015 11:47:37,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[MANIFESTATION],[MANIFESTATION],"MICROANGIOPATHIC HEMOLYSIS suggest HU<span id=""transmark""></span>S",n/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:58:16,1634031112,5/11/2015 11:57:19,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[MANIFESTATION],[MANIFESTATION],strongly suggest,N/a,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:58:30,1634031196,5/11/2015 11:58:01,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[SYMPTOM],[SYMPTOM],strongly suggest,N/A,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412921,5/11/2015 11:58:45,1634031256,5/11/2015 11:58:18,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[MANIFESTATION],[MANIFESTATION],strongly suggest,N/A,0,139,1,25,142,TWrex-cause,813624-FS1,"MICROANGIOPATHIC HEMOLYSIS neutrophilic leukocytosis, and a negative direct Coombs test (direct antiglobulin test) strongly suggest TTP or HUS",MICROANGIOPATHIC HEMOLYSIS,HUS
718412922,5/11/2015 09:55:34,1633999523,5/11/2015 09:55:07,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],characterized,n/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 09:56:48,1633999935,5/11/2015 09:55:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"LAURENCE MOON SYNDROME is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",N/A,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 09:57:46,1634000181,5/11/2015 09:57:18,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[SYMPTOM],[SYMPTOM],characterized,N/A,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:07:29,1634002803,5/11/2015 10:07:09,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:07:50,1634002888,5/11/2015 10:07:06,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:11:16,1634003671,5/11/2015 10:10:48,false,prodege,1,20693658,USA,IL,Chicago,66.87.79.8,[SYMPTOM],[SYMPTOM],characterized by,N/A,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:18:55,1634005833,5/11/2015 10:18:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:23:16,1634007077,5/11/2015 10:22:51,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],characterized,Symptom,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:25:55,1634007822,5/11/2015 10:24:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",characterized by,N/A,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:27:57,1634008437,5/11/2015 10:27:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:35:56,1634010781,5/11/2015 10:34:54,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],characterized,no none,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:42:29,1634012442,5/11/2015 10:41:55,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],characterized by,N/A,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 10:52:48,1634014976,5/11/2015 10:52:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],characterized,n/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 11:16:19,1634020860,5/11/2015 11:15:18,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,N/A,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412922,5/11/2015 11:21:06,1634021961,5/11/2015 11:20:37,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[MANIFESTATION],[MANIFESTATION],is characterized by,N/a,53,0,1,70,22,TWrex-cause,812898-FS1,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME
718412923,5/11/2015 12:37:56,1634043380,5/11/2015 12:37:25,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",may cause,n/a,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 12:47:42,1634046520,5/11/2015 12:47:13,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],abnormality,dsd,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 12:51:24,1634047634,5/11/2015 12:50:54,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",accompanied by,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 12:56:02,1634049146,5/11/2015 12:54:27,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,none,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 12:57:45,1634049746,5/11/2015 12:57:11,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],mitral regurgitation,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 13:00:26,1634050518,5/11/2015 13:00:04,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 13:50:05,1634067664,5/11/2015 13:49:36,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MITRAL VALVE PROLAPSE accompanied by MARFAN SYNDROME,n/a,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 13:58:08,1634071065,5/11/2015 13:57:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 13:58:44,1634071398,5/11/2015 13:58:21,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,n/a,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 13:59:13,1634071663,5/11/2015 13:58:08,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 14:00:42,1634072331,5/11/2015 13:59:23,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 14:01:24,1634072699,5/11/2015 14:00:23,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CAUSES],[CAUSES],may cause some degree of mitral regurgitation,N/A,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 14:04:47,1634075326,5/11/2015 14:04:06,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,n/a,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 14:05:58,1634076995,5/11/2015 14:05:17,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS] [ASSOCIATED_WITH],"[PREVENTS]
[ASSOCIATED_WITH]",MITRAL VALVE PROLAPSE accompanied by MARFAN SYNDROME,n/a,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412923,5/11/2015 14:06:38,1634078186,5/11/2015 14:05:17,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CAUSES],[CAUSES],accompanied,n/a,0,128,1,20,143,TWrex-cause,812931-FS1,MITRAL VALVE PROLAPSE is usually an isolated abnormality but may cause some degree of mitral regurgitation or be accompanied by MARFAN SYNDROME or an atrial septal defect.,MITRAL VALVE PROLAPSE,MARFAN SYNDROME
718412924,5/11/2015 10:11:58,1634003871,5/11/2015 10:11:40,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],treatment,N/A,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:22:46,1634006931,5/11/2015 10:21:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 60 and 90 mg dosages.,N/A,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:26:10,1634007902,5/11/2015 10:25:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],intravenous therapy,n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:32:04,1634009681,5/11/2015 10:31:44,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:41:57,1634012242,5/11/2015 10:41:37,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treats,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:45:54,1634013262,5/11/2015 10:45:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for the treatment of,n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:50:22,1634014426,5/11/2015 10:49:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 10:57:55,1634016322,5/11/2015 10:57:36,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 11:16:07,1634020817,5/11/2015 11:15:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 11:32:24,1634024774,5/11/2015 11:32:07,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 11:37:42,1634026159,5/11/2015 11:37:29,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 11:50:47,1634029163,5/11/2015 11:50:20,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"PAMIDRONATE treatment of HYPE<span id=""transmark""></span>RCALCEMIA",n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 12:00:04,1634031575,5/11/2015 11:59:47,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],the treatment of,N/A,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 12:09:43,1634034299,5/11/2015 12:09:22,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treatment,N/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412924,5/11/2015 12:22:22,1634038279,5/11/2015 12:21:52,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,113,80,-1,125,91,TWrex-cause,800953-FS1,"Nussbaum SR, Younger J, VandePol CJ et al. Single dose intravenous therapy with PAMIDRONATE for the treatment of HYPERCALCEMIA of malignancy: comparison of 30 , 60 , and 90 mg dosages.",HYPERCALCEMIA,PAMIDRONATE
718412925,5/11/2015 14:00:00,1634071954,5/11/2015 13:59:28,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treated for,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:00:44,1634072371,5/11/2015 14:00:03,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treated,n/a,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:02:45,1634073503,5/11/2015 14:01:46,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treated for,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:05:41,1634076569,5/11/2015 14:05:13,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],treated for,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:05:55,1634076903,5/11/2015 14:05:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treated,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:07:44,1634080308,5/11/2015 14:07:20,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treated,n/a,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:08:22,1634081659,5/11/2015 14:07:58,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treated,n/a,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:08:37,1634082209,5/11/2015 14:07:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PHARMACOKINETICS OF TERBINAFINE in children treated for TINEA CAPITIS.,n/a,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:13:53,1634088658,5/11/2015 14:13:03,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],treated,n/a,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 14:39:33,1634099799,5/11/2015 14:38:48,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.225,[TREATS],[TREATS],in young children treated for,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 15:28:06,1634119632,5/11/2015 15:27:12,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],PHARMACOKINETICS OF TERBINAFINE treated for TINEA CAPITIS.,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 15:48:32,1634126566,5/11/2015 15:48:09,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],treated for,N/a,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 15:50:31,1634127205,5/11/2015 15:49:15,false,prodege,1,29350031,USA,SC,Columbia,98.71.2.249,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 15:58:46,1634130081,5/11/2015 15:58:01,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],treated,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412925,5/11/2015 16:18:12,1634137949,5/11/2015 16:17:18,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[OTHER],[OTHER],treated,N/A,117,55,-1,129,86,TWrex-cause,803551-FS1,"Abdel Rahman SM, Herron J, Fallon Friedlander S et al. PHARMACOKINETICS OF TERBINAFINE in young children treated for TINEA CAPITIS.",TINEA CAPITIS,PHARMACOKINETICS OF TERBINAFINE
718412926,5/11/2015 10:13:06,1634004095,5/11/2015 10:12:47,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],caused,N/A,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:26:56,1634008165,5/11/2015 10:26:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:27:12,1634008230,5/11/2015 10:25:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER] [CAUSES],"[CAUSES]
[OTHER]","MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by NEISSERIA MENINGITIDIS and is transmitted person to person by the respiratory route.",N/A,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:34:06,1634010277,5/11/2015 10:33:49,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:43:21,1634012618,5/11/2015 10:42:58,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],caused,Caused by,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:47:23,1634013573,5/11/2015 10:47:09,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:52:22,1634014880,5/11/2015 10:51:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 10:59:07,1634016645,5/11/2015 10:58:35,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 11:17:18,1634021061,5/11/2015 11:17:01,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 11:33:26,1634025011,5/11/2015 11:33:09,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],caused by,N/A,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 11:38:26,1634026307,5/11/2015 11:38:13,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 11:53:32,1634029929,5/11/2015 11:53:09,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"MENINGOCOCCAL INFECTION is caused by NEISSERIA M<span id=""transmark""></span>ENINGITIDIS",n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 12:05:22,1634033187,5/11/2015 12:03:00,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[MANIFESTATION],[MANIFESTATION],caused by,N/A,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 12:11:30,1634034911,5/11/2015 12:11:02,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[CAUSES],[CAUSES],illness caused by,N/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412926,5/11/2015 12:23:17,1634038498,5/11/2015 12:22:46,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SIDE_EFFECT],[SIDE_EFFECT],caused,n/a,25,98,1,47,120,TWrex-cause,811176-FS1,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS
718412927,5/11/2015 10:05:49,1634002374,5/11/2015 10:05:16,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],ABUSE,N/A,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:15:26,1634004943,5/11/2015 10:14:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]",OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,N/A,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:24:23,1634007409,5/11/2015 10:24:07,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including use,n/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:26:46,1634008131,5/11/2015 10:25:17,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],nonmedical use,n/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:33:46,1634010206,5/11/2015 10:33:15,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including,Including,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:40:24,1634011832,5/11/2015 10:39:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including nonmedical use of,n/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:46:21,1634013334,5/11/2015 10:45:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],including,N/A,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 10:55:24,1634015565,5/11/2015 10:55:02,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],including,n/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:04:26,1634018068,5/11/2015 11:03:41,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PART_OF],[PART_OF],including,n/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:29:39,1634024074,5/11/2015 11:28:29,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],ABUSE,N/A,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:32:59,1634024919,5/11/2015 11:32:47,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:46:02,1634028022,5/11/2015 11:45:28,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[IS_A],[IS_A],"OPIOID ABUSE PRESCRIPTION OPIOIDS i<span id=""transmark""></span>s",n/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:56:04,1634030599,5/11/2015 11:54:47,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[OTHER],[OTHER],use of,N/A,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:56:30,1634030659,5/11/2015 11:55:55,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",including,N/a,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412927,5/11/2015 11:56:43,1634030676,5/11/2015 11:55:53,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including nonmedical use of,N/A,13,54,1,24,74,TWrex-cause,815137-FS1,Rationale: • OPIOID ABUSE including nonmedical use of PRESCRIPTION OPIOIDS is a significant public health problem.,OPIOID ABUSE,PRESCRIPTION OPIOIDS
718412928,5/11/2015 14:04:10,1634074683,5/11/2015 14:03:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],reduce,N/A,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 14:05:21,1634076129,5/11/2015 14:05:08,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],reduce,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 14:14:23,1634088908,5/11/2015 14:13:49,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],reduce,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 14:15:51,1634089537,5/11/2015 14:15:29,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[PREVENTS],[PREVENTS],reduce daily,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 14:16:28,1634089773,5/11/2015 14:15:41,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],may reduce adjunctive treatment,N/A,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 14:17:21,1634090139,5/11/2015 14:16:39,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],CAPSAICIN may reduce INTERCOURSE RELATED PAIN;,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 14:41:19,1634100485,5/11/2015 14:40:21,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",may reduce,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 15:34:16,1634121871,5/11/2015 15:34:00,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],Topical application of CAPSAICIN may reduce daily and INTERCOURSE RELATED PAIN;,N/A,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 16:11:21,1634134959,5/11/2015 16:09:57,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],may reduce,N/A,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 16:25:45,1634143210,5/11/2015 16:24:48,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[TREATS],[TREATS],reduce,N/A,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 16:32:30,1634146889,5/11/2015 16:31:45,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[TREATS],[TREATS],reduce,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 16:47:42,1634154521,5/11/2015 16:47:23,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 17:22:08,1634171737,5/11/2015 17:21:52,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",12 weeks may reduce daily and INTERCOURSE,n/a,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 17:34:49,1634190534,5/11/2015 17:34:24,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],reduce daily,reduce means you take them,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412928,5/11/2015 17:35:40,1634192184,5/11/2015 17:35:07,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],CAPSAICIN may reduce INTERCOURSE RELATED PAIN;,N/A,69,25,-1,92,34,TWrex-cause,803950-FS1,• Topical application of CAPSAICIN for 12 weeks may reduce daily and INTERCOURSE RELATED PAIN; adjunctive treatment with topical lidocaine is often necessary.,INTERCOURSE RELATED PAIN,CAPSAICIN
718412929,5/11/2015 10:09:06,1634003173,5/11/2015 10:08:30,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]","toxoplasmosis,",N/A,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:21:48,1634006632,5/11/2015 10:20:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",N/A,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:25:54,1634007820,5/11/2015 10:25:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],result from,n/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:31:43,1634009613,5/11/2015 10:31:06,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SYMPTOM],[SYMPTOM],can also result from,n/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:41:36,1634012166,5/11/2015 10:40:50,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],result,Side effect,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:45:30,1634013172,5/11/2015 10:45:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],can result from,n/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:49:55,1634014293,5/11/2015 10:49:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],result from,N/A,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 10:57:35,1634016237,5/11/2015 10:57:02,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],can also result from,n/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 11:15:45,1634020724,5/11/2015 11:15:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],result from,n/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 11:32:05,1634024729,5/11/2015 11:31:44,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],result,N/A,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 11:37:27,1634026093,5/11/2015 11:37:14,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 11:50:19,1634029050,5/11/2015 11:49:21,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[CAUSES],[CAUSES],"LYMPHADENOPATHY result from INFECTIOUS MONONUCLEOSIS toxop<span id=""transmark""></span>lasmosis,",n/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 11:59:46,1634031550,5/11/2015 11:59:24,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",can also result from,N/A,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 12:09:20,1634034218,5/11/2015 12:08:43,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[CAUSES],[CAUSES],can also result from,N/a,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412929,5/11/2015 12:22:23,1634038280,5/11/2015 12:21:42,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],result,N/A,9,46,1,23,70,TWrex-cause,814049-FS1,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS
718412930,5/11/2015 12:16:12,1634036338,5/11/2015 12:16:00,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],in the treatment,N/A,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:27:16,1634039734,5/11/2015 12:26:57,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:29:00,1634040300,5/11/2015 12:28:40,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],treatment,N/A,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:29:30,1634040382,5/11/2015 12:29:03,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment of,n/a,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:34:07,1634042099,5/11/2015 12:33:52,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[PREVENTS],[PREVENTS],HYPERTENSION,fc,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:36:02,1634042790,5/11/2015 12:34:54,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,HYPERTENSION can be treated with  ACEBUTOLOL,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:40:00,1634044106,5/11/2015 12:39:40,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HYPERTENSION,N/A,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:41:07,1634044464,5/11/2015 12:40:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ACEBUTOLOL in the treatment of HYPERTENSION,n/a,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:41:13,1634044504,5/11/2015 12:41:02,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:42:05,1634044744,5/11/2015 12:41:39,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],in the treatment of patients with,N/A,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:44:14,1634045457,5/11/2015 12:43:55,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",in the treatment of,treated by,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:47:26,1634046468,5/11/2015 12:47:06,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],treatment of,N/A,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:50:10,1634047312,5/11/2015 12:49:33,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],ACEBUTOLOL in treatment of HYPERTENSION,na,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:53:38,1634048343,5/11/2015 12:53:13,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of,N/A,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412930,5/11/2015 12:54:58,1634048686,5/11/2015 12:54:06,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],ACEBUTOLOL treatment patients HYPERTENSION renal functional impairment.,na,45,0,-1,56,10,TWrex-cause,803835-FS1,ACEBUTOLOL in the treatment of patients with HYPERTENSION and renal functional impairment.,HYPERTENSION,ACEBUTOLOL
718412931,5/11/2015 12:27:49,1634039942,5/11/2015 12:27:28,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:29:44,1634040445,5/11/2015 12:29:19,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],prone,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:30:14,1634040635,5/11/2015 12:29:47,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],people with,n/a,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:35:43,1634042672,5/11/2015 12:35:28,false,neodev,1.0,31726043,USA,DE,Wilmington,199.115.115.214,[CAUSES],[CAUSES],more,dvdc,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:38:36,1634043596,5/11/2015 12:37:49,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],prone,none,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:41:01,1634044436,5/11/2015 12:40:32,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],SCOLIOSIS,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:42:01,1634044693,5/11/2015 12:41:26,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[OTHER],[OTHER],prone,prone to,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:42:31,1634044863,5/11/2015 12:42:07,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NPS are more prone to SCOLIOSIS,n/a,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:42:52,1634045082,5/11/2015 12:42:20,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",are more prone to,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:46:03,1634046079,5/11/2015 12:44:41,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",are more prone to,causes,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:48:27,1634046795,5/11/2015 12:47:47,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[ASSOCIATED_WITH],[ASSOCIATED_WITH],more prone to,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:52:32,1634047966,5/11/2015 12:51:28,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],people with NPS are more prone to SCOLIOSIS,na,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 12:54:32,1634048587,5/11/2015 12:54:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],prone to,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 13:35:58,1634062687,5/11/2015 13:34:11,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],prone,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412931,5/11/2015 13:40:24,1634064408,5/11/2015 13:38:27,false,clixsense,1.0,23144069,GBR,G6,Hull,83.100.235.226,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prone,N/A,73,38,1,81,41,TWrex-cause,813516-FS1,"Also, some research shows people with NPS are more prone to glaucoma and SCOLIOSIS due to poorly developed spines.",SCOLIOSIS,NPS
718412932,5/11/2015 09:57:00,1634000000,5/11/2015 09:56:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 09:58:41,1634000389,5/11/2015 09:58:21,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],treatment,N/A,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 09:59:38,1634000757,5/11/2015 09:58:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[IS_A],[IS_A],Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,N/A,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:08:10,1634002986,5/11/2015 10:07:50,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for the treatment of,n/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:09:26,1634003231,5/11/2015 10:09:06,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:19:38,1634006040,5/11/2015 10:19:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for the treatment of,n/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:24:39,1634007511,5/11/2015 10:24:10,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treatment of,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:28:57,1634008674,5/11/2015 10:28:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:29:03,1634008739,5/11/2015 10:28:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for the treatment of,n/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:37:38,1634011247,5/11/2015 10:36:41,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,no none,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:43:23,1634012622,5/11/2015 10:43:03,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],for the treatment,N/A,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 10:54:34,1634015432,5/11/2015 10:54:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 11:18:52,1634021383,5/11/2015 11:17:19,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",treatment,N/A,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 11:22:09,1634022207,5/11/2015 11:21:50,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],for the treatment of,N/a,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412932,5/11/2015 11:28:47,1634023824,5/11/2015 11:28:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,96,47,-1,137,74,TWrex-cause,800609-FS1,"Iberti TJ, Benjamin E, Paluch TA et al. Use of CONSTANT INFUSION VERAPAMIL for the treatment of POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA",POSTOPERATIVE SUPRAVENTRICULAR TACHYCARDIA,CONSTANT INFUSION VERAPAMIL
718412933,5/11/2015 11:58:05,1634031069,5/11/2015 11:57:28,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[PART_OF],[PART_OF],"MS RELATED SYMPTOMS including SPASTICITY pai<span id=""transmark""></span>n,",n/a,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:09:57,1634034339,5/11/2015 12:09:45,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[SYMPTOM],[SYMPTOM],including,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:26:09,1634039355,5/11/2015 12:25:45,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],SYMPTOMS,n/a,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:26:51,1634039630,5/11/2015 12:26:08,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[PART_OF],[PART_OF],beneficial,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:28:05,1634039998,5/11/2015 12:27:39,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],various SYMPTOMS,n/a,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:32:16,1634041376,5/11/2015 12:30:58,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],including,none,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:33:03,1634041597,5/11/2015 12:32:34,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[SYMPTOM],[SYMPTOM],beneficial,sdd,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:37:29,1634043200,5/11/2015 12:36:14,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],MS RELATED SYMPTOMS,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:38:38,1634043627,5/11/2015 12:37:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],various MS RELATED SYMPTOMS including SPASTICITY,n/a,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:39:13,1634043812,5/11/2015 12:38:51,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[PART_OF],[PART_OF],including,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:40:08,1634044122,5/11/2015 12:39:47,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],SYMPTOMS including,n/a,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:41:29,1634044594,5/11/2015 12:41:12,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SIDE_EFFECT],[SIDE_EFFECT],including,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:45:10,1634045789,5/11/2015 12:44:26,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[IS_A],[IS_A],including,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:46:46,1634046245,5/11/2015 12:45:38,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM],[SYMPTOM],MS RELATED SYMPTOMS including SPASTICITY,na,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412933,5/11/2015 12:52:10,1634047868,5/11/2015 12:51:40,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],beneficial effect on,N/A,114,84,1,123,103,TWrex-cause,813120-FS1,"COMMENTARY  It has been suggested that marijuana has a beneficial effect on various MS RELATED SYMPTOMS including SPASTICITY pain, and tremor.",SPASTICITY,MS RELATED SYMPTOMS
718412934,5/11/2015 12:30:38,1634040752,5/11/2015 12:30:23,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treat,n/a,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:34:03,1634042090,5/11/2015 12:33:36,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],used to treat,n/a,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:34:20,1634042165,5/11/2015 12:33:59,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:42:46,1634044985,5/11/2015 12:42:29,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],including,sdsdx,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:46:42,1634046211,5/11/2015 12:46:23,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:48:24,1634046786,5/11/2015 12:47:58,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treat,none,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:50:30,1634047403,5/11/2015 12:50:04,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],ARTHRITIS,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:50:45,1634047448,5/11/2015 12:49:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],treat RHEUMATOID ARTHRITIS including GOLD SALTS,n/a,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 12:55:51,1634049062,5/11/2015 12:55:13,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 13:46:39,1634066371,5/11/2015 13:46:01,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 13:51:42,1634068282,5/11/2015 13:50:52,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],to treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 13:52:30,1634068620,5/11/2015 13:51:33,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],used to treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 13:55:11,1634069692,5/11/2015 13:54:37,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treat,n/a,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 13:55:24,1634069802,5/11/2015 13:55:06,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treat,N/A,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412934,5/11/2015 13:57:09,1634070621,5/11/2015 13:56:47,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treat,n/a,39,70,-1,58,80,TWrex-cause,804532-FS1,"Other long acting agents used to treat RHEUMATOID ARTHRITIS including GOLD SALTS penicillamine, and hydroxychloroquine, are not effective in ankylosing spondylitis.",RHEUMATOID ARTHRITIS,GOLD SALTS
718412935,5/11/2015 10:05:16,1634002177,5/11/2015 10:04:50,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],OVERDOSE,N/A,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:14:11,1634004444,5/11/2015 10:13:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]","OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",N/A,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:24:07,1634007320,5/11/2015 10:23:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],result from,n/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:25:16,1634007616,5/11/2015 10:22:51,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],result from,n/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:33:13,1634010028,5/11/2015 10:32:13,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],result,Results,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:39:41,1634011727,5/11/2015 10:38:45,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can result from,n/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:45:36,1634013181,5/11/2015 10:44:49,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",can result from,N/A,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 10:55:01,1634015511,5/11/2015 10:54:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],can result from,n/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:03:40,1634017835,5/11/2015 11:03:06,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],result,n/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:28:28,1634023747,5/11/2015 11:27:57,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[CAUSES],[CAUSES],result,N/A,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:32:46,1634024877,5/11/2015 11:32:28,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:45:26,1634027877,5/11/2015 11:44:26,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[SIDE_EFFECT],[SIDE_EFFECT],"OVERDOSE can result from DR<span id=""transmark""></span>UG",n/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:54:45,1634030227,5/11/2015 11:53:42,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[CAUSES],[CAUSES],can result,N/A,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:55:52,1634030502,5/11/2015 11:55:21,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],result from,N/A,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412935,5/11/2015 11:55:54,1634030541,5/11/2015 11:55:20,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[CAUSES],[CAUSES],can result from the DRUG,N/a,0,69,1,7,73,TWrex-cause,810495-FS1,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG
718412936,5/11/2015 14:05:23,1634076153,5/11/2015 14:05:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 14:06:41,1634078250,5/11/2015 14:06:23,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 14:16:59,1634089928,5/11/2015 14:16:36,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 14:20:20,1634091472,5/11/2015 14:18:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated SARCOMA (AIDS/KS:,n/a,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 14:44:32,1634101720,5/11/2015 14:43:28,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 15:35:26,1634122293,5/11/2015 15:34:56,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 16:27:15,1634144297,5/11/2015 16:26:48,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 16:34:28,1634147715,5/11/2015 16:33:56,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 16:48:34,1634154839,5/11/2015 16:48:23,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 17:23:25,1634173042,5/11/2015 17:23:08,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",(ZDV IN AIDS associated Kaposi's SARCOMA,n/a,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 17:36:35,1634194005,5/11/2015 17:36:02,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,it says associated,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 17:38:22,1634197642,5/11/2015 17:37:48,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 17:45:08,1634212580,5/11/2015 17:44:40,false,instagc,1.0,23035364,USA,NJ,Blackwood,50.153.127.6,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 17:53:50,1634233957,5/11/2015 17:51:56,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS SARCOMA (AIDS/KS:,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412936,5/11/2015 18:32:05,1634270882,5/11/2015 18:30:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,109,53,-1,124,88,TWrex-cause,800210-FS1,"Krown SE, Bundow B, Gansbacher W et al. Interferon α (IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS associated Kaposi's SARCOMA (AIDS/KS: an ongoing phase I trial.",SARCOMA (AIDS/KS,(IFN Α PLUS ZIDOVUDINE (ZDV IN AIDS
718412937,5/11/2015 12:32:27,1634041416,5/11/2015 12:32:07,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],for,n/a,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 12:36:44,1634042986,5/11/2015 12:36:07,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[PART_OF],[PART_OF],United Network for,n/a,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 12:46:40,1634046228,5/11/2015 12:46:12,false,neodev,1.0,31726043,USA,DE,Wilmington,199.115.115.214,[LOCATION],[LOCATION],Services,cdcd,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 12:50:38,1634047435,5/11/2015 12:50:00,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[NONE],[NONE],N/A,No apparent relation.,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 12:53:59,1634048426,5/11/2015 12:52:25,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,No relationship has been made between these terms.,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 12:56:26,1634049345,5/11/2015 12:55:35,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],TRANSPLANTATION,N/A,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 12:59:45,1634050299,5/11/2015 12:57:58,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[NONE],[NONE],N?A,not medical terms,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 13:49:19,1634067325,5/11/2015 13:48:09,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[PART_OF],[PART_OF],TRANSPLANTATION ROCKVILLE MD; ORGAN SHARING RICHMOND VA ARBOR RESEARCH,n/a,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 13:56:57,1634070543,5/11/2015 13:55:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,"These are not medical terms per se, but talking about the name of a building and research enter which really do not fit any of the relations presented as choices.",126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 13:57:30,1634070778,5/11/2015 13:57:13,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 13:57:59,1634070976,5/11/2015 13:57:07,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,This is just a list of hospitals,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 13:58:53,1634071518,5/11/2015 13:57:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[NONE],[NONE],N/A,They are just names of Health departments,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 13:59:28,1634071769,5/11/2015 13:57:53,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"for Health,",N/A,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 14:03:34,1634074086,5/11/2015 14:02:37,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Division,n/a,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412937,5/11/2015 14:04:33,1634075118,5/11/2015 14:02:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Division of TRANSPLANTATION ROCKVILLE MD; for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE,n/a,126,175,-1,153,229,TWrex-cause,800576-FS1,"Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of TRANSPLANTATION ROCKVILLE MD; United Network for ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE for Health, Ann Arbor, MI. [ Full Text ]  6.",TRANSPLANTATION ROCKVILLE MD,ORGAN SHARING RICHMOND VA ARBOR RESEARCH COLLABORATIVE
718412938,5/11/2015 14:02:24,1634073322,5/11/2015 14:02:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:03:17,1634073882,5/11/2015 14:03:07,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:08:45,1634082517,5/11/2015 14:07:41,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:11:03,1634087307,5/11/2015 14:10:43,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:12:06,1634087857,5/11/2015 14:10:48,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],treatment,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:12:10,1634087904,5/11/2015 14:11:34,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],for the treatment of,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:13:03,1634088315,5/11/2015 14:12:05,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],DIVALPROEX for treatment of BIPOLAR MANIA:,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:15:32,1634089417,5/11/2015 14:15:09,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 14:22:47,1634092452,5/11/2015 14:20:21,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],for the treatment of,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 15:30:37,1634120574,5/11/2015 15:30:08,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],DIVALPROEX for the treatment of BIPOLAR MANIA:,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 16:07:02,1634133242,5/11/2015 16:06:23,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],treatment of,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 16:21:15,1634139832,5/11/2015 16:20:53,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[TREATS],[TREATS],treatment,N/A,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 16:28:24,1634145041,5/11/2015 16:28:01,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[TREATS],[TREATS],treatment,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 16:46:11,1634153620,5/11/2015 16:45:52,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412938,5/11/2015 17:20:32,1634170226,5/11/2015 17:20:15,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DIVALPROEX for the treatment,n/a,98,66,-1,110,76,TWrex-cause,803448-FS1,"Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or DIVALPROEX for the treatment of BIPOLAR MANIA: a randomized, double blind, placebo controlled study.",BIPOLAR MANIA,DIVALPROEX
718412939,5/11/2015 12:15:43,1634036170,5/11/2015 12:15:29,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],glycemic control,N/A,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:26:36,1634039506,5/11/2015 12:26:09,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],control,n/a,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:27:37,1634039823,5/11/2015 12:26:52,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],Treatment,N/A,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:28:38,1634040212,5/11/2015 12:28:06,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],adjunct to insulin therapy,n/a,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:33:21,1634041733,5/11/2015 12:33:08,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],adjunct,ffsdf,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:34:16,1634042159,5/11/2015 12:32:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,TYPE 2 DIABETES MELLITUS and  INSULIN THERAPY = relationship mot known,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:39:14,1634043827,5/11/2015 12:37:30,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[TREATS],[TREATS],DIABETES,N/A,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:39:33,1634043877,5/11/2015 12:38:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],TYPE 2 DIABETES MELLITUS therapy INSULIN THERAPY,n/a,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:40:31,1634044234,5/11/2015 12:40:09,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:40:53,1634044367,5/11/2015 12:39:14,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients on,N/A,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:42:05,1634044747,5/11/2015 12:41:30,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",Treatment of,treated by,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:46:05,1634046093,5/11/2015 12:45:11,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],Treatment THERAPY,N/A,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:48:13,1634046732,5/11/2015 12:46:47,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],TYPE 2 DIABETES MELLITUS control INSULIN THERAPY,na,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:52:47,1634048021,5/11/2015 12:52:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment of,N/A,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412939,5/11/2015 12:53:10,1634048115,5/11/2015 12:52:09,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],Treatment TYPE 2 DIABETES MELLITUS adjunct preprandial insulin therapy with or without concomitant metformin sulfonylurea patients without adequate glycemic control INSULIN THERAPY alone in combination with metformin and/or sulfonylurea.,na,13,192,-1,36,207,TWrex-cause,800335-FS1,Treatment of TYPE 2 DIABETES MELLITUS as an adjunct to preprandial insulin therapy with or without concomitant metformin and/or a sulfonylurea in patients without adequate glycemic control on INSULIN THERAPY alone or in combination with metformin and/or a sulfonylurea.,TYPE 2 DIABETES MELLITUS,INSULIN THERAPY
718412940,5/11/2015 10:12:47,1634004047,5/11/2015 10:12:30,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS],[PREVENTS],reduces,N/A,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:25:38,1634007715,5/11/2015 10:24:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [SIDE_EFFECT],"[PREVENTS]
[SIDE_EFFECT]","When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome or percutaneous coronary intervention",N/A,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:26:41,1634008102,5/11/2015 10:26:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],reduces risk,n/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:33:48,1634010214,5/11/2015 10:33:00,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SIDE_EFFECT],[SIDE_EFFECT],reduces risk,n/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:42:57,1634012524,5/11/2015 10:42:27,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],reduces,Reduces the risk,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:47:07,1634013484,5/11/2015 10:46:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],reduces risk for,n/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:51:55,1634014798,5/11/2015 10:51:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],reduces risk for,N/A,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 10:58:34,1634016491,5/11/2015 10:58:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],reduces risk for,n/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 11:17:00,1634020988,5/11/2015 11:16:33,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],reduces risk,n/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 11:33:08,1634024938,5/11/2015 11:32:41,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],reduces,N/A,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 11:38:11,1634026290,5/11/2015 11:37:58,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 11:53:08,1634029858,5/11/2015 11:52:12,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[OTHER],[OTHER],"CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary sy<span id=""transmark""></span>ndrome",n/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 12:02:58,1634032527,5/11/2015 12:02:15,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]","reduces risk for death,",N/A,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 12:11:01,1634034716,5/11/2015 12:10:26,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],reduces risk for,N/a,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412940,5/11/2015 12:22:55,1634038410,5/11/2015 12:22:23,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",reduces,N/A,59,23,-1,77,34,TWrex-cause,800853-FS1,"When added to aspirin, CLOPIDOGREL reduces risk for death, MI AND STROKE AFTER an acute coronary syndrome  (1)  or percutaneous coronary intervention  (2).",MI AND STROKE AFTER,CLOPIDOGREL
718412941,5/11/2015 10:03:25,1634001704,5/11/2015 10:02:41,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:09:13,1634003199,5/11/2015 10:07:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"33 Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",N/A,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:17:38,1634005545,5/11/2015 10:16:00,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[MANIFESTATION],[MANIFESTATION],include,n/a,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:22:39,1634006895,5/11/2015 10:22:23,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,n/a,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:29:57,1634009040,5/11/2015 10:29:15,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PART_OF],[PART_OF],include,Include,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:36:47,1634010983,5/11/2015 10:35:08,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,"OCULAR HYPERTELORISM is shown as being a symptom of Leopard syndrome, not NOONAN SYNDROME",110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:41:19,1634012073,5/11/2015 10:40:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],include,N/A,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:48:00,1634013766,5/11/2015 10:47:32,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],syndromes include,N/A,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 10:53:11,1634015033,5/11/2015 10:52:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[NONE],[NONE],N/A,it is bracketed with a different syndrome,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 11:00:59,1634017101,5/11/2015 10:59:26,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PART_OF],[PART_OF],include LEOPARD syndrome,n/a,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 11:23:49,1634022473,5/11/2015 11:23:18,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF],[PART_OF],include,N/A,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 11:31:32,1634024578,5/11/2015 11:31:18,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 11:41:32,1634026961,5/11/2015 11:39:29,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[NONE] [TREATS],"[TREATS]
[NONE]",n/a,"both are symptoms of a disease, otherwise there is no corelation between them",110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 11:51:44,1634029398,5/11/2015 11:50:26,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[OTHER],[OTHER],Familial lentiginosis syndromes,N/A,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412941,5/11/2015 11:53:53,1634030009,5/11/2015 11:52:56,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PART_OF],[PART_OF],include,N/a,110,206,1,129,221,TWrex-cause,812834-FS1,"33  Familial lentiginosis syndromes include LEOPARD syndrome (lentigines, electrocardiographic abnormalities, OCULAR HYPERTELORISM pulmonary artery stenosis, abnormal genitalia, retarded growth, deafness), NOONAN SYNDROME Carney complex, and Peutz Jeghers syndrome.",OCULAR HYPERTELORISM,NOONAN SYNDROME
718412942,5/11/2015 10:07:02,1634002634,5/11/2015 10:05:50,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],antibiotics,N/A,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:17:27,1634005472,5/11/2015 10:15:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]","DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity 23 Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity 1 2 Avoid concurrent or sequential use, if possible 1 2 β Lactam antibiotics (cephalosporins, penicillins.",N/A,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:24:39,1634007512,5/11/2015 10:24:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],suppress nausea,n/a,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:28:23,1634008541,5/11/2015 10:26:47,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],suppress nausea and vomiting of,n/a,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:34:29,1634010362,5/11/2015 10:33:48,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],suppress,Treated with,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:42:46,1634012469,5/11/2015 10:40:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS] [CONTRAINDICATES],"[TREATS]
[CONTRAINDICATES]",suppress nausea and vomiting MAY MASK SYMPTOMS,drug treating one condition may mask symptoms of another,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:47:18,1634013548,5/11/2015 10:46:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],suppress,N/A,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 10:55:51,1634015696,5/11/2015 10:55:25,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],suppress,n/a,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:05:01,1634018248,5/11/2015 11:04:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],suppress nausea and vomiting of,n/a,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:30:21,1634024223,5/11/2015 11:29:40,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],suppress,N/A,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:33:15,1634024963,5/11/2015 11:33:01,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:47:35,1634028398,5/11/2015 11:46:03,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[NONE],[NONE],n/a,"""VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS"" too many keywords in this phrase",81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:57:18,1634030812,5/11/2015 11:56:31,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],suppress,N/a,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:57:59,1634031059,5/11/2015 11:56:06,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],suppress nausea and vomiting,N/A,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412942,5/11/2015 11:58:17,1634031118,5/11/2015 11:56:44,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]","Avoid concurrent or sequential use,",N/A,81,6,-1,127,43,TWrex-cause,804937-FS1,"e.g., DIMENHYDRINATE MECLIZINE ANTI EMETICS that suppress nausea and vomiting of VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS of vestibular ototoxicity [ 23 ]    Bacitracin Possible increased incidence of nephrotoxicity and/or neurotoxicity [ 1 , 2 ] Avoid concurrent or sequential use, if possible [ 1 , 2 ]   β Lactam antibiotics (cephalosporins, penicillins.",VESTIBULAR ORIGIN AND VERTIGO MAY MASK SYMPTOMS,DIMENHYDRINATE MECLIZINE ANTI EMETICS
718412943,5/11/2015 14:04:57,1634075526,5/11/2015 14:04:40,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 14:06:22,1634077667,5/11/2015 14:05:46,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],cause,n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 14:15:29,1634089388,5/11/2015 14:14:57,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 14:16:35,1634089798,5/11/2015 14:16:09,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CAUSES],[CAUSES],cause,n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 14:18:27,1634090568,5/11/2015 14:18:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],ENDOMETRIOSIS found to be cause of PAIN,n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 14:43:28,1634101210,5/11/2015 14:42:56,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[CAUSES],[CAUSES],found to be the cause,n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 15:34:55,1634122062,5/11/2015 15:34:39,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],ENDOMETRIOSIS was found to be the cause of the PAIN,N/A,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 16:13:04,1634135635,5/11/2015 16:11:56,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[CAUSES],[CAUSES],cause,N/A,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 16:26:47,1634143940,5/11/2015 16:26:16,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[CAUSES],[CAUSES],cause,N/A,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 16:33:55,1634147518,5/11/2015 16:33:22,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[CAUSES],[CAUSES],cause,n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 16:48:21,1634154778,5/11/2015 16:48:05,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 17:23:07,1634172655,5/11/2015 17:22:41,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","chronic pelvic pain,",n/a,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 17:36:00,1634192846,5/11/2015 17:35:18,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],to be the cause,found to be a cause,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 17:37:46,1634196356,5/11/2015 17:36:25,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CAUSES],[CAUSES],ENDOMETRIOSIS was the cause of PAIN,N/A,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412943,5/11/2015 17:44:39,1634211477,5/11/2015 17:44:18,false,instagc,1.0,23035364,USA,NJ,Blackwood,50.153.127.6,[CAUSES],[CAUSES],cause,na,105,58,1,108,71,TWrex-cause,813492-FS1,"In three large studies of women with chronic pelvic pain, ENDOMETRIOSIS was found to be the cause of the PAIN in 70 to 80% of cases.",PAIN,ENDOMETRIOSIS
718412944,5/11/2015 12:32:05,1634041292,5/11/2015 12:31:50,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],with,n/a,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:36:06,1634042791,5/11/2015 12:35:43,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],Management of,n/a,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:36:41,1634042944,5/11/2015 12:36:01,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[SIDE_EFFECT],[SIDE_EFFECT],outbreaks,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:46:01,1634046059,5/11/2015 12:45:24,false,neodev,1.0,31726043,USA,DE,"",108.59.8.217,[SYMPTOM],[SYMPTOM],SCABIES,csd,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:49:59,1634047276,5/11/2015 12:49:22,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],Management of,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:52:23,1634047942,5/11/2015 12:51:55,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Management,none,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:55:34,1634048932,5/11/2015 12:55:02,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],SCABIES,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 12:57:56,1634049787,5/11/2015 12:57:34,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",Management of,treated by,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 13:48:09,1634066931,5/11/2015 13:47:40,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],Management of outbreaks of SCABIES with PERMETHRIN,n/a,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 13:54:06,1634069324,5/11/2015 13:52:43,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Management with,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 13:55:18,1634069709,5/11/2015 13:54:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],Management of,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 13:57:06,1634070602,5/11/2015 13:56:54,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],Management,n/a,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 13:57:12,1634070650,5/11/2015 13:56:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Management of endemic outbreaks,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 13:57:48,1634070892,5/11/2015 13:56:57,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],Management of,N/A,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412944,5/11/2015 14:02:36,1634073423,5/11/2015 14:02:06,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],outbreaks,n/a,59,83,-1,65,93,TWrex-cause,804661-FS1,"Paasch U, Haustein U F: Management of endemic outbreaks of SCABIES with allethrin, PERMETHRIN and ivermectin.",SCABIES,PERMETHRIN
718412945,5/11/2015 12:28:32,1634040181,5/11/2015 12:28:21,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:31:11,1634040921,5/11/2015 12:30:48,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],caused,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:31:14,1634040927,5/11/2015 12:31:00,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],caused by,n/a,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:37:59,1634043420,5/11/2015 12:37:41,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[LOCATION],[LOCATION],gained,dcsc,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:41:21,1634044547,5/11/2015 12:40:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused by,none,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:42:38,1634044918,5/11/2015 12:42:13,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],ANTHRAX,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:42:49,1634045060,5/11/2015 12:42:39,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused by,n/a,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:43:44,1634045314,5/11/2015 12:43:28,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],caused by,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:45:37,1634045948,5/11/2015 12:44:46,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],ANTHRAX caused by B ANTHRACIS,n/a,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:48:26,1634046792,5/11/2015 12:47:45,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",caused by,caused by,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:49:23,1634047088,5/11/2015 12:49:08,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[CAUSES],[CAUSES],caused by,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 12:55:23,1634048860,5/11/2015 12:54:22,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],ANTHRAX caused by B ANTHRACIS,na,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 13:39:22,1634063976,5/11/2015 13:38:52,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused by,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 13:45:07,1634065967,5/11/2015 13:44:14,false,clixsense,1.0,23144069,GBR,G6,Hull,83.100.235.226,[MANIFESTATION],[MANIFESTATION],caused by,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412945,5/11/2015 13:47:10,1634066535,5/11/2015 13:45:15,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CAUSES],[CAUSES],caused by,N/A,0,18,1,6,29,TWrex-cause,811593-FS1,ANTHRAX caused by B ANTHRACIS has gained new importance as a potential bioterrorism weapon after the 2001 attacks.,ANTHRAX,B ANTHRACIS
718412946,5/11/2015 12:28:05,1634039997,5/11/2015 12:27:50,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:30:18,1634040651,5/11/2015 12:29:46,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",treatment,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:30:37,1634040751,5/11/2015 12:30:17,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment of,n/a,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:36:19,1634042842,5/11/2015 12:35:52,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[CAUSES],[CAUSES],tamoxifen,vcvx,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:39:44,1634043990,5/11/2015 12:38:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],using,none,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:41:28,1634044589,5/11/2015 12:41:02,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[PREVENTS],[PREVENTS],DACARBAZINE,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:42:20,1634044832,5/11/2015 12:42:02,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],chemotherapy,n/a,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:43:15,1634045167,5/11/2015 12:42:53,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],treatment of patients with,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:43:45,1634045318,5/11/2015 12:42:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],treatment of patients with METASTATIC MELANOMA using DACARBAZINE,n/a,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:47:21,1634046417,5/11/2015 12:46:05,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",treatment of,treated by,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:48:47,1634046903,5/11/2015 12:48:27,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],treatment,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 12:53:39,1634048349,5/11/2015 12:52:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],treatment of patients with METASTATIC MELANOMA using DACARBAZINE,na,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 13:37:22,1634063300,5/11/2015 13:35:59,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 13:43:13,1634065250,5/11/2015 13:40:25,false,clixsense,1.0,23144069,GBR,G6,Hull,83.100.235.226,[OTHER],[OTHER],using,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412946,5/11/2015 13:46:13,1634066277,5/11/2015 13:45:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,113,168,-1,131,179,TWrex-cause,803731-FS1,"Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Prospective randomized trial of the treatment of patients with METASTATIC MELANOMA using chemotherapy with cisplatin, DACARBAZINE and tamoxifen alone or in combination with interleukin 2 and interferon alfa 2b.",METASTATIC MELANOMA,DACARBAZINE
718412947,5/11/2015 10:00:09,1634000840,5/11/2015 09:59:13,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[SIDE_EFFECT],[SIDE_EFFECT],WMEROPENEM,N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:01:59,1634001306,5/11/2015 10:01:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:09:19,1634003224,5/11/2015 10:08:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:10:33,1634003561,5/11/2015 10:10:04,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:20:29,1634006296,5/11/2015 10:20:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment of,n/a,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:26:23,1634007972,5/11/2015 10:25:55,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treatment of,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:31:11,1634009498,5/11/2015 10:30:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment,n/a,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:32:07,1634009682,5/11/2015 10:30:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:44:45,1634012982,5/11/2015 10:44:10,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],the treatment of,N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 10:56:51,1634016011,5/11/2015 10:56:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 11:20:25,1634021733,5/11/2015 11:20:00,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 11:23:36,1634022437,5/11/2015 11:23:10,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],treatment,N/a,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 11:29:22,1634024004,5/11/2015 11:29:07,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",no,no,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 11:34:37,1634025329,5/11/2015 11:32:34,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"WMEROPENEM treatment FEBRILE NEU<span id=""transmark""></span>TROPENIA:",nice weather but I haven't selected [none],117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412947,5/11/2015 11:46:19,1634028095,5/11/2015 11:45:37,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],treatment,N/A,117,47,-1,135,56,TWrex-cause,800068-FS1,"1]  Feld R, DePauw B, Berman S, Keating A, Ho WMEROPENEM versus ceftazidime in the treatment of cancer patients with FEBRILE NEUTROPENIA: a randomized, double blind trial.",FEBRILE NEUTROPENIA,MEROPENEM
718412948,5/11/2015 12:38:18,1634043512,5/11/2015 12:37:57,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],efficacy of,n/a,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 12:48:10,1634046693,5/11/2015 12:47:48,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],"finasteride,",fdfds,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 12:52:13,1634047877,5/11/2015 12:51:25,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",efficacy of,N/A,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 12:56:31,1634049383,5/11/2015 12:56:02,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],efficacy,none,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 12:58:35,1634049997,5/11/2015 12:57:47,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],TERAZOSIN,N/A,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 13:00:44,1634050614,5/11/2015 13:00:29,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",efficacy,treated by,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 13:50:56,1634067962,5/11/2015 13:50:06,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],TERAZOSIN in BENIGN PROSTATIC HYPERPLASIA,n/a,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 13:58:31,1634071271,5/11/2015 13:58:09,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],efficacy,N/A,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 13:59:05,1634071605,5/11/2015 13:58:44,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],efficacy,n/a,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 13:59:58,1634071934,5/11/2015 13:59:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],efficacy of,N/A,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 14:02:02,1634073047,5/11/2015 14:00:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],efficacy,N/A,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 14:03:31,1634074062,5/11/2015 14:01:31,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[IS_A],[IS_A],efficacy of,N/A,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 14:06:28,1634077849,5/11/2015 14:04:47,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],in,n/a,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 14:06:31,1634077987,5/11/2015 14:05:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],"efficacy of TERAZOSIN finasteride, in BENIGN PROSTATIC HYPERPLASIA",n/a,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412948,5/11/2015 14:07:07,1634079105,5/11/2015 14:06:38,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[MANIFESTATION],[MANIFESTATION],both,n/a,90,56,-1,117,65,TWrex-cause,804702-FS1,"Lepor H, Williford WO, Barry MJ, et al: The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
718412949,5/11/2015 11:39:25,1634026445,5/11/2015 11:39:14,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 11:56:06,1634030603,5/11/2015 11:55:37,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"HYPERKALEMIA treat with SODIUM BICA<span id=""transmark""></span>RBONATE",n/a,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:08:58,1634034144,5/11/2015 12:06:22,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],treat as indicated,N/A,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:13:39,1634035527,5/11/2015 12:13:14,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],treat with,N/a,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:24:46,1634038981,5/11/2015 12:24:10,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",discontinue treat,N/A,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:24:57,1634039031,5/11/2015 12:24:28,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treat,n/a,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:26:18,1634039431,5/11/2015 12:25:41,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treat as indicated with,n/a,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:28:11,1634040043,5/11/2015 12:26:44,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],discontinue and treat,HYPERKALEMIA should be treated with   SODIUM BICARBONATE,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:31:21,1634040979,5/11/2015 12:31:08,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],discontinue,fdff,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:33:47,1634042025,5/11/2015 12:32:12,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],"parenteral calcium chloride,",N/A,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:35:29,1634042558,5/11/2015 12:34:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],HYPERKALEMIA treat as indicated with SODIUM BICARBONATE,n/a,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:37:44,1634043293,5/11/2015 12:37:14,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],treat with,N/A,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:39:10,1634043787,5/11/2015 12:38:47,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treat,n/a,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:39:42,1634043982,5/11/2015 12:39:17,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",treat as indicated with,Treated by,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412949,5/11/2015 12:43:27,1634045265,5/11/2015 12:42:37,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],treat,N/A,8,110,-1,19,128,TWrex-cause,803737-FS1,"256  If HYPERKALEMIA occurs, immediately discontinue and treat as indicated with parenteral calcium chloride, SODIUM BICARBONATE and/or oral or parenteral glucose with a rapid acting insulin preparation.",HYPERKALEMIA,SODIUM BICARBONATE
718412950,5/11/2015 14:01:24,1634072687,5/11/2015 14:01:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],resolves,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:02:23,1634073328,5/11/2015 14:01:47,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:05:35,1634076445,5/11/2015 14:04:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",drug induced,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:09:41,1634084691,5/11/2015 14:09:14,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:09:42,1634084713,5/11/2015 14:08:47,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],has been associated with,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:10:00,1634085403,5/11/2015 14:09:34,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[IS_A],[IS_A],DRUG,n/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:10:47,1634087072,5/11/2015 14:10:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],LUPUS SYNDROME resolves when DRUG is stopped.,n/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:11:07,1634087366,5/11/2015 14:08:45,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SIDE_EFFECT] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",associated with,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:18:14,1634090472,5/11/2015 14:17:05,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",drug induced,n/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 14:41:21,1634100503,5/11/2015 14:40:42,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.225,[SYMPTOM],[SYMPTOM],has been associated with a drug induced,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 15:29:12,1634120090,5/11/2015 15:28:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],LUPUS SYNDROME which resolves when the DRUG is stopped.,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 16:04:34,1634132338,5/11/2015 16:04:02,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[CAUSES],[CAUSES],drug induced,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 16:19:56,1634138964,5/11/2015 16:19:25,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 16:24:53,1634142463,5/11/2015 16:24:12,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[CAUSES],[CAUSES],associated with a drug,N/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412950,5/11/2015 16:26:36,1634143862,5/11/2015 16:25:11,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[CAUSES],[CAUSES],induced,n/a,88,127,1,101,131,TWrex-cause,811911-FS1,"Long term, high dose (> 300 mg/day) hydralazine has been associated with a drug induced LUPUS SYNDROME which resolves when the DRUG is stopped.",LUPUS SYNDROME,DRUG
718412951,5/11/2015 14:03:29,1634074053,5/11/2015 14:02:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],as well.,N/A,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:04:48,1634075337,5/11/2015 14:04:20,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],SYSTEMIC LUPUS ERYTHEMATOSUS,n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:12:01,1634087839,5/11/2015 14:11:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],often show,N/A,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:12:49,1634088208,5/11/2015 14:12:12,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:14:34,1634089077,5/11/2015 14:13:50,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is commonly associated with,N/A,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:14:48,1634089165,5/11/2015 14:13:51,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:15:52,1634089564,5/11/2015 14:14:57,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SYSTEMIC LUPUS ERYTHEMATOSUS commonly associated with TUBULOINTERSTITIAL NEPHRITIS,n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 14:30:43,1634096283,5/11/2015 14:29:41,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],commonly associated with,n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 15:32:42,1634121375,5/11/2015 15:32:20,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with TUBULOINTERSTITIAL NEPHRITIS,N/A,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 16:08:48,1634133898,5/11/2015 16:08:07,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 16:24:05,1634141846,5/11/2015 16:22:44,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 16:31:03,1634146256,5/11/2015 16:30:19,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[ASSOCIATED_WITH],[ASSOCIATED_WITH],show,n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 16:47:09,1634154283,5/11/2015 16:46:59,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 17:21:30,1634171109,5/11/2015 17:21:10,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL",n/a,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412951,5/11/2015 17:34:00,1634189062,5/11/2015 17:33:36,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,it says associated with in it,176,0,1,203,28,TWrex-cause,811913-FS1,"SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER IMMUNE COMPLEX DISEASES  Although SYSTEMIC LUPUS ERYTHEMATOSUS is commonly associated with glomerular lesions, renal biopsies often show TUBULOINTERSTITIAL NEPHRITIS or immune complex deposits along the tubular basement membrane as well.",TUBULOINTERSTITIAL NEPHRITIS,SYSTEMIC LUPUS ERYTHEMATOSUS
718412952,5/11/2015 10:08:28,1634003086,5/11/2015 10:07:54,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],reduced unstable ANGINA,N/A,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:20:34,1634006327,5/11/2015 10:19:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,N/A,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:25:42,1634007727,5/11/2015 10:25:25,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],reduced combined coronary events,n/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:31:05,1634009471,5/11/2015 10:30:15,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],reduced combined coronary events,n/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:40:49,1634011954,5/11/2015 10:39:59,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],reduced,Reduced by,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:45:05,1634013063,5/11/2015 10:44:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced coronary events,n/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:49:14,1634014041,5/11/2015 10:48:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],reduced,N/A,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 10:57:01,1634016061,5/11/2015 10:56:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],reduced,n/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 11:15:22,1634020681,5/11/2015 11:14:26,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],reduced coronary events,n/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 11:31:43,1634024593,5/11/2015 11:31:23,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],reduced,N/A,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 11:37:12,1634026001,5/11/2015 11:37:00,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [PREVENTS] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 11:49:19,1634028839,5/11/2015 11:48:47,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"ENOXAPARIN reduced A<span id=""transmark""></span>NGINA",n/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 11:59:22,1634031425,5/11/2015 11:59:04,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],reduced combined,N/A,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 12:08:42,1634034065,5/11/2015 12:07:51,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],reduced in unstable,N/a,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412952,5/11/2015 12:21:41,1634038022,5/11/2015 12:21:03,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],reduced,N/A,56,0,-1,61,10,TWrex-cause,800231-FS1,ENOXAPARIN reduced combined coronary events in unstable ANGINA and non Q wave MI at 14 and 30 days.,ANGINA,ENOXAPARIN
718412953,5/11/2015 10:03:55,1634001802,5/11/2015 10:03:27,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS],[PREVENTS],prevention,N/A,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:10:05,1634003366,5/11/2015 10:09:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.,N/A,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:18:46,1634005805,5/11/2015 10:17:39,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],prevention,n/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:22:55,1634006994,5/11/2015 10:22:40,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],blind trial,n/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:30:24,1634009176,5/11/2015 10:29:59,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PREVENTS],[PREVENTS],prevention,Prevention of,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:37:33,1634011225,5/11/2015 10:36:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],primary prevention of,n/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:42:37,1634012455,5/11/2015 10:41:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],prevention of,N/A,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:48:31,1634013853,5/11/2015 10:48:02,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[PREVENTS],[PREVENTS],primary prevention,N/A,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 10:53:31,1634015101,5/11/2015 10:53:12,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],prevention of,n/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 11:01:26,1634017231,5/11/2015 11:01:00,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevention,n/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 11:24:05,1634022524,5/11/2015 11:23:50,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],prevention,N/A,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 11:31:52,1634024645,5/11/2015 11:31:34,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 11:42:20,1634027182,5/11/2015 11:41:35,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[PREVENTS],[PREVENTS],"ASPIRIN prevention of MYOCARDIAL IN<span id=""transmark""></span>FARCTION",n/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 11:52:11,1634029609,5/11/2015 11:51:45,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[PREVENTS],[PREVENTS],prevention of,N/A,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412953,5/11/2015 11:54:15,1634030101,5/11/2015 11:53:54,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],primary prevention,N/a,131,98,-1,151,105,TWrex-cause,804313-FS1,"1]  Juul Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double blind trial of ASPIRIN in primary prevention of MYOCARDIAL INFARCTION in patients with stable chronic angina pectoris.",MYOCARDIAL INFARCTION,ASPIRIN
718412954,5/11/2015 11:57:26,1634030891,5/11/2015 11:57:06,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[PREVENTS],[PREVENTS],"ATENOLOL prevention of MYOCARDIAL INFA<span id=""transmark""></span>RCTION",n/a,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:09:45,1634034306,5/11/2015 12:09:31,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[PREVENTS],[PREVENTS],in prevention of,N/A,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:25:44,1634039228,5/11/2015 12:25:29,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],prevention of,n/a,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:26:06,1634039344,5/11/2015 12:25:35,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[PREVENTS],[PREVENTS],prevention,N/A,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:27:38,1634039830,5/11/2015 12:27:07,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[PREVENTS],[PREVENTS],in prevention of,n/a,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:30:58,1634040825,5/11/2015 12:29:35,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],prevention,MYOCARDIAL INFARCTION may be prevented by ATENOLO,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:32:28,1634041425,5/11/2015 12:32:12,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[MANIFESTATION],[MANIFESTATION],prevention,ddac,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:36:13,1634042808,5/11/2015 12:35:47,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],MYOCARDIAL INFARCTION,N/A,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:36:59,1634043060,5/11/2015 12:35:57,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],ATENOLOL in prevention of MYOCARDIAL INFARCTION,n//a,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:38:49,1634043684,5/11/2015 12:38:33,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[PREVENTS],[PREVENTS],in prevention of,N/A,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:39:44,1634043986,5/11/2015 12:39:30,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[PREVENTS],[PREVENTS],in prevention,n/a,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:41:10,1634044469,5/11/2015 12:40:01,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",in prevention of,prevents,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:44:24,1634045485,5/11/2015 12:44:04,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[PREVENTS],[PREVENTS],prevention,N/A,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:45:37,1634045955,5/11/2015 12:44:22,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],ATENOLOL prevention of MYOCARDIAL INFARCTION,na,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412954,5/11/2015 12:51:38,1634047666,5/11/2015 12:50:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],prevention of,N/A,72,46,-1,92,54,TWrex-cause,805248-FS1,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL
718412955,5/11/2015 09:53:11,1633998865,5/11/2015 09:52:23,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],treatment,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 09:53:54,1633998995,5/11/2015 09:52:48,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 09:54:33,1633999205,5/11/2015 09:53:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],FDA drug approval summary: ALEMTUZUMAB treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:05:15,1634002171,5/11/2015 10:04:36,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:06:37,1634002541,5/11/2015 10:06:17,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment for,n/a,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:09:21,1634003222,5/11/2015 10:08:51,false,prodege,1.0,20693658,USA,IL,Chicago,66.87.79.8,[TREATS],[TREATS],treatment for,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:18:14,1634005688,5/11/2015 10:17:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],single agent treatment,n/a,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:22:04,1634006732,5/11/2015 10:21:06,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treatment,Treated by,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:22:06,1634006743,5/11/2015 10:21:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment for,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:26:42,1634008101,5/11/2015 10:25:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],single agent treatment for,n/a,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:33:41,1634010184,5/11/2015 10:32:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,no none,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:41:15,1634012056,5/11/2015 10:40:46,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],treatment for,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 10:51:19,1634014605,5/11/2015 10:50:35,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 11:13:16,1634020117,5/11/2015 11:10:50,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],treatment,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412955,5/11/2015 11:18:02,1634021263,5/11/2015 11:16:15,false,clixsense,1,18158338,NLD,09,Utrecht,82.161.141.243,[TREATS],[TREATS],single agent treatment,N/A,115,71,-1,147,82,TWrex-cause,803984-FS1,"2]  Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: ALEMTUZUMAB as single agent treatment for B CELL CHRONIC LYMPHOCYTIC LEUKEMIA",CELL CHRONIC LYMPHOCYTIC LEUKEMIA,ALEMTUZUMAB
718412956,5/11/2015 12:30:07,1634040607,5/11/2015 12:29:56,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:33:05,1634041617,5/11/2015 12:32:47,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],treatment of,n/a,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:33:17,1634041714,5/11/2015 12:32:59,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS],[TREATS],treatment,N/A,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:42:08,1634044748,5/11/2015 12:41:36,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[LOCATION],[LOCATION],severe,ccxzcz,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:44:03,1634045374,5/11/2015 12:43:54,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:45:49,1634046036,5/11/2015 12:45:33,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS],[TREATS],in the treatment of,N/A,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:46:27,1634046164,5/11/2015 12:45:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:49:07,1634047019,5/11/2015 12:48:44,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],alATORVASTATIN,N/A,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:49:17,1634047071,5/11/2015 12:49:03,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alATORVASTATIN in the treatment of HYPERCHOLESTEROLEMIA,n/a,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 12:54:24,1634048524,5/11/2015 12:53:38,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",treatment of,treated by,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 13:43:03,1634065168,5/11/2015 13:42:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 13:49:09,1634067288,5/11/2015 13:48:23,false,instagc,1.0,29444531,USA,GA,Conyers,184.37.250.198,[NONE],[NONE],NONE,no relation,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 13:49:55,1634067575,5/11/2015 13:49:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 13:50:03,1634067637,5/11/2015 13:49:27,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],treatment of,N/A,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412956,5/11/2015 13:54:26,1634069386,5/11/2015 13:54:02,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,79,39,-1,98,51,TWrex-cause,803346-FS1,"Heinonen T, Stein E, Issacsohn J, et alATORVASTATIN in the treatment of severe HYPERCHOLESTEROLEMIA",HYPERCHOLESTEROLEMIA,ATORVASTATIN
718412957,5/11/2015 14:02:38,1634073439,5/11/2015 14:02:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:03:29,1634074051,5/11/2015 14:03:18,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:09:02,1634083151,5/11/2015 14:08:46,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:11:32,1634087626,5/11/2015 14:11:04,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:12:29,1634088072,5/11/2015 14:12:06,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SIDE_EFFECT],[SIDE_EFFECT],caused,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:12:45,1634088175,5/11/2015 14:12:15,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:13:44,1634088587,5/11/2015 14:13:05,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],CHANCROID caused by HAEMOPHILUS DUCREYI.,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:15:57,1634089580,5/11/2015 14:15:33,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 14:23:29,1634092762,5/11/2015 14:22:48,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],Treatment,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 15:31:17,1634120923,5/11/2015 15:30:37,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],CHANCROID caused by HAEMOPHILUS DUCREYI.,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 16:07:18,1634133336,5/11/2015 16:07:03,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 16:21:42,1634140088,5/11/2015 16:21:17,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 16:29:07,1634145401,5/11/2015 16:28:25,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[CAUSES],[CAUSES],caused by,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 16:46:32,1634153876,5/11/2015 16:46:12,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[CAUSES],[CAUSES],caused by,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412957,5/11/2015 17:20:49,1634170496,5/11/2015 17:20:33,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Treatment of CHANCROID,n/a,29,50,1,37,69,TWrex-cause,810551-FS1,137  Chancroid  Treatment of CHANCROID caused by  HAEMOPHILUS DUCREYI.,CHANCROID,HAEMOPHILUS DUCREYI
718412958,5/11/2015 14:02:54,1634073616,5/11/2015 14:02:39,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],preventing,N/A,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:04:18,1634074858,5/11/2015 14:03:30,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],more effective than,n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:11:05,1634087353,5/11/2015 14:09:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],more effective,"The test is saying that LOW MOLECULAR WEIGHT HEPARIN is an alternative or better treatment than 
LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS so really does not fit well with any choices.",240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:12:11,1634087915,5/11/2015 14:11:33,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[OTHER],[OTHER],effective,n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:13:45,1634088591,5/11/2015 14:12:49,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[PREVENTS],[PREVENTS],more effective than compression stockings for preventing DVT,N/A,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:13:51,1634088627,5/11/2015 14:12:30,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SYMPTOM],[SYMPTOM],"Fibrinolytic agents Heparin,",n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:14:54,1634089186,5/11/2015 14:13:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],LOW MOLECULAR WEIGHT HEPARIN for preventing LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 14:29:39,1634095782,5/11/2015 14:26:41,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],more effective,n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 15:32:19,1634121228,5/11/2015 15:31:18,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,"The Low Molecular Weight Stockings are just a keyword, and the paper itself is talking about how one is better than the other.",240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 16:08:06,1634133619,5/11/2015 16:07:20,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[PREVENTS],[PREVENTS],preventing,N/A,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 16:22:42,1634140803,5/11/2015 16:21:44,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[OTHER],[OTHER],more effective,N/A,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 16:30:18,1634145916,5/11/2015 16:29:08,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[OTHER],[OTHER],Keywords:,n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 16:46:57,1634154175,5/11/2015 16:46:33,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[NONE],[NONE],none,none fit,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 17:21:09,1634170778,5/11/2015 17:20:49,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],more effective than compression stockings preventing,n/a,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412958,5/11/2015 17:34:12,1634189431,5/11/2015 17:33:13,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Keywords:,N/A,240,0,-1,288,28,TWrex-cause,804558-FS1,"LOW MOLECULAR WEIGHT HEPARIN for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy  Hematology/Thrombosis  About Star Ratings  Keywords: Arthroplasty, replacement, knee Fibrinolytic agents Heparin, LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS compression Venous thromboembolism Venous Thrombosis  ACP Journal Club.",LOW MOLECULAR WEIGHT PULMONARY EMBOLISM STOCKINGS,LOW MOLECULAR WEIGHT HEPARIN
718412959,5/11/2015 14:06:14,1634077407,5/11/2015 14:05:53,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],institute,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 14:07:36,1634080014,5/11/2015 14:07:06,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CONTRAINDICATES],[CONTRAINDICATES],discontinue,n/a,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 14:21:51,1634092131,5/11/2015 14:21:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],Immediately discontinue ANESTHETIC AGENTS as soon as MALIGNANT HYPERTHERMIA is recognized.,n/a,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 14:46:55,1634102652,5/11/2015 14:46:02,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[PREVENTS],[PREVENTS],Immediately discontinue,n/a,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 15:18:17,1634115933,5/11/2015 15:17:57,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],crisis recognized.,n/a,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 15:36:18,1634122665,5/11/2015 15:35:50,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CONTRAINDICATES],[CONTRAINDICATES],Immediately discontinue all ANESTHETIC AGENTS as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 16:28:35,1634145164,5/11/2015 16:27:48,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[OTHER],[OTHER],discontinue,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 16:35:22,1634148011,5/11/2015 16:35:00,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[SIDE_EFFECT],[SIDE_EFFECT],crisis,n/a,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 17:38:10,1634197261,5/11/2015 17:37:09,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],and,associated with,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 17:40:07,1634201343,5/11/2015 17:39:12,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[SYMPTOM] [CONTRAINDICATES],"[SYMPTOM]
[CONTRAINDICATES]",discontinue all ANESTHETIC AGENTS as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 17:45:54,1634214267,5/11/2015 17:45:29,false,instagc,1.0,23035364,USA,NJ,Blackwood,50.153.127.6,[CAUSES],[CAUSES],recognized.,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 17:55:01,1634237141,5/11/2015 17:54:26,false,gptking,1.0,31799065,USA,IL,Marion,50.45.43.154,[CAUSES],[CAUSES],ANESTHETIC AGENTS MALIGNANT HYPERTHERMIA,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 18:33:55,1634271936,5/11/2015 18:33:13,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Immediately discontinue,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 18:36:59,1634273680,5/11/2015 18:36:21,false,bitcoinget,1,31256687,USA,NY,Brooklyn,69.112.8.202,[OTHER],[OTHER],as soon as,n/a,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412959,5/11/2015 18:44:50,1634278299,5/11/2015 18:43:17,false,clixsense,1,6362702,GBR,B7,Bristol,90.222.102.171,[CONTRAINDICATES],[CONTRAINDICATES],discontinue institute,N/A,124,67,1,145,84,TWrex-cause,811489-FS1,109  Malignant Hyperthermia Crisis  •  Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS
718412960,5/11/2015 13:59:27,1634071764,5/11/2015 13:58:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],infusion:,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:00:02,1634071969,5/11/2015 13:59:25,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],Comparison,n/a,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:01:45,1634072902,5/11/2015 14:01:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],continuous subcutaneous insulin infusion:,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:05:08,1634075796,5/11/2015 14:04:24,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Comparison of,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:05:25,1634076228,5/11/2015 14:03:01,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],continuous subcutaneous insulin infusion:,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:07:19,1634079461,5/11/2015 14:06:54,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],study,n/a,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:07:47,1634080447,5/11/2015 14:06:57,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],INSULIN LISPRO infusion: TYPE 1 DIABETES,n/a,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:07:57,1634080770,5/11/2015 14:07:33,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],randomized study,n/a,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:13:02,1634088268,5/11/2015 14:11:26,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[OTHER] [TREATS] [PREVENTS],"[TREATS]
[PREVENTS]
[OTHER]",randomized study,n/a,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 14:38:47,1634099563,5/11/2015 14:38:00,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.225,[TREATS],[TREATS],in continuous subcutaneous insulin infusion:,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 15:27:11,1634119263,5/11/2015 15:25:28,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],INSULIN LISPRO continuous subcutaneous insulin infusion: in TYPE 1 DIABETES,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 15:48:07,1634126482,5/11/2015 15:47:15,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],a study in,N/a,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 15:49:14,1634126828,5/11/2015 15:47:03,false,prodege,1.0,29350031,USA,SC,Columbia,98.71.2.249,[ASSOCIATED_WITH],[ASSOCIATED_WITH],INSULIN LISPRO in continuous subcutaneous insulin infusion: randomized study in TYPE 1 DIABETES,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 15:58:00,1634129800,5/11/2015 15:55:57,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],Comparison,none,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412960,5/11/2015 16:17:16,1634137499,5/11/2015 16:16:28,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[TREATS],[TREATS],subcutaneous insulin infusion:,N/A,172,90,-1,186,104,TWrex-cause,800519-FS1,"Bode B, Weinstein R, Bell D et al. Comparison of insulin aspart with buffered insulin and INSULIN LISPRO in continuous subcutaneous insulin infusion: a randomized study in TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
718412961,5/11/2015 12:30:58,1634040828,5/11/2015 12:30:39,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:34:34,1634042290,5/11/2015 12:34:04,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",increased risk of,n/a,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:34:54,1634042379,5/11/2015 12:34:21,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[ASSOCIATED_WITH],[ASSOCIATED_WITH],documented,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:43:09,1634045140,5/11/2015 12:42:53,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[LOCATION],[LOCATION],viscosity,cscxsc,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:48:00,1634046662,5/11/2015 12:46:43,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",increased risk of,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:49:31,1634047129,5/11/2015 12:48:24,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],increased risk,none,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:51:26,1634047636,5/11/2015 12:50:32,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],viscosity,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:51:55,1634047796,5/11/2015 12:50:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],PV subsequent increased risk HEMORRHAGE,n/a,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 12:56:19,1634049288,5/11/2015 12:55:53,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",subsequent,caused by,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 13:49:26,1634067365,5/11/2015 13:46:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",subsequent,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 13:52:39,1634068704,5/11/2015 13:51:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",subsequent increased risk of,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 13:53:23,1634069048,5/11/2015 13:52:35,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 13:55:37,1634069916,5/11/2015 13:55:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],increased risk,n/a,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 13:55:47,1634070005,5/11/2015 13:55:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],increased risk,N/A,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412961,5/11/2015 13:56:11,1634070184,5/11/2015 13:55:09,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,166,111,1,175,113,TWrex-cause,814641-FS1,Evidence: • Several studies documented the increased blood viscosity associated with high hematocrit levels in PV and the subsequent increased risk of thrombosis and HEMORRHAGE ( 29 ;  30 ;  31.,HEMORRHAGE,PV
718412962,5/11/2015 10:07:53,1634002898,5/11/2015 10:07:33,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS],[PREVENTS],preventing,N/A,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:19:23,1634006006,5/11/2015 10:18:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",N/A,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:25:24,1634007660,5/11/2015 10:25:03,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],preventing relapse,n/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:30:13,1634009127,5/11/2015 10:29:57,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],preventing,n/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:39:57,1634011768,5/11/2015 10:39:35,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PREVENTS],[PREVENTS],preventing,Helps prevnt,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:44:21,1634012847,5/11/2015 10:43:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],in preventing relapse of,n/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:48:42,1634013887,5/11/2015 10:48:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],preventing,N/A,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 10:56:37,1634015988,5/11/2015 10:56:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],preventing,n/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 11:14:25,1634020398,5/11/2015 11:14:05,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],preventing,n/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 11:31:22,1634024527,5/11/2015 11:31:07,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PREVENTS],[PREVENTS],preventing,N/A,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 11:36:58,1634025942,5/11/2015 11:34:36,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 11:48:46,1634028764,5/11/2015 11:48:12,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[PREVENTS],[PREVENTS],"SERTRALINE preventing relapse of<span id=""transmark""></span> POSTTRAUMATIC STRESS DISORDER:",n/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 11:58:35,1634031234,5/11/2015 11:58:17,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[PREVENTS],[PREVENTS],preventing,N/a,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 11:59:03,1634031343,5/11/2015 11:58:46,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[PREVENTS],[PREVENTS],in preventing relapse,N/A,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412962,5/11/2015 12:21:02,1634037858,5/11/2015 12:19:21,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[PREVENTS],[PREVENTS],preventing,N/A,48,12,-1,76,22,TWrex-cause,804721-FS1,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE
718412963,5/11/2015 14:02:09,1634073162,5/11/2015 14:01:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:03:06,1634073776,5/11/2015 14:02:43,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],reduce,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:07:40,1634080169,5/11/2015 14:07:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:10:41,1634086958,5/11/2015 14:10:27,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:10:48,1634087090,5/11/2015 14:10:29,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:11:29,1634087619,5/11/2015 14:10:50,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[TREATS],[TREATS],Consider the LNG IUS to reduce,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:12:02,1634087854,5/11/2015 14:11:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAIN associated with ENDOMETRIOSIS,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:15:08,1634089279,5/11/2015 14:14:02,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 14:20:20,1634091481,5/11/2015 14:19:37,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[SYMPTOM],[SYMPTOM],associated with,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 15:30:06,1634120399,5/11/2015 15:29:54,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],PAIN associated with ENDOMETRIOSIS,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 16:06:21,1634132954,5/11/2015 16:05:21,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 16:20:52,1634139556,5/11/2015 16:20:27,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[SYMPTOM],[SYMPTOM],associated with,N/A,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 16:28:00,1634144835,5/11/2015 16:27:25,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 16:45:51,1634153454,5/11/2015 16:45:24,false,clixsense,1.0,6417722,USA,MI,Taylor,99.170.106.105,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412963,5/11/2015 17:22:41,1634172127,5/11/2015 17:22:29,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],reduce PAIN associated,n/a,35,56,1,38,69,TWrex-cause,812862-FS1,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS
718412964,5/11/2015 10:04:23,1634001959,5/11/2015 10:03:57,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[MANIFESTATION],[MANIFESTATION],with,N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:11:58,1634003865,5/11/2015 10:10:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"PROGRESSIVE SUPRANUCLEAR PALSY (Steele Richardson Olszewski Syndrome) PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:20:02,1634006156,5/11/2015 10:18:46,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],causing with,n/a,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:23:23,1634007105,5/11/2015 10:22:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"rare, disorder",n/a,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:31:20,1634009560,5/11/2015 10:30:26,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],causing,Causes,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:38:18,1634011378,5/11/2015 10:37:34,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causing,n/a,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:43:39,1634012654,5/11/2015 10:42:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causing,N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:49:08,1634014004,5/11/2015 10:48:32,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[MANIFESTATION],[MANIFESTATION],causing,N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 10:54:08,1634015308,5/11/2015 10:53:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],with,n/a,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 11:02:23,1634017519,5/11/2015 11:01:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],with PROGRESSIVE AXIAL DYSTONIA,n/a,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 11:25:01,1634022725,5/11/2015 11:24:06,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[PART_OF] [CAUSES],"[CAUSES]
[PART_OF]",causing,N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 11:32:08,1634024732,5/11/2015 11:31:54,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",no,no,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 11:43:04,1634027323,5/11/2015 11:42:21,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[IS_A],[IS_A],"PROGRESSIVE SUPRANUCLEAR PALSY PROGRESSIVE SUPRANUCLEAR PALSY i<span id=""transmark""></span>s",n/a,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 11:53:06,1634029863,5/11/2015 11:52:13,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[SYMPTOM],[SYMPTOM],causing,N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412964,5/11/2015 11:54:49,1634030239,5/11/2015 11:54:13,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",with,N/A,218,0,1,243,30,TWrex-cause,814006-FS1,"PROGRESSIVE SUPRANUCLEAR PALSY  (Steele Richardson Olszewski Syndrome)  PROGRESSIVE SUPRANUCLEAR PALSY is a rare, degenerative CNS disorder causing loss of voluntary eye movements, bradykinesia, muscular rigidity with PROGRESSIVE AXIAL DYSTONIA pseudobulbar palsy, and dementia.",PROGRESSIVE AXIAL DYSTONIA,PROGRESSIVE SUPRANUCLEAR PALSY
718412965,5/11/2015 12:28:45,1634040244,5/11/2015 12:28:33,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treat,n/a,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:31:36,1634041057,5/11/2015 12:31:15,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[TREATS],[TREATS],used to treat,n/a,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:31:54,1634041184,5/11/2015 12:31:13,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treat prevent,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:38:36,1634043592,5/11/2015 12:38:14,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CYTOMEGALOVIRUS,cc,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:42:14,1634044809,5/11/2015 12:41:22,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],used to treat,none,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:43:01,1634045133,5/11/2015 12:42:50,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",treat or prevent,n/a,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:44:09,1634045393,5/11/2015 12:43:45,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treat or prevent,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:44:33,1634045513,5/11/2015 12:42:42,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],CYTOMEGALOVIRUS,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:46:39,1634046199,5/11/2015 12:45:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION,n/a,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:49:50,1634047234,5/11/2015 12:49:23,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treat prevent,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 12:50:19,1634047339,5/11/2015 12:48:27,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",used to treat or prevent,treated by,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 13:39:45,1634064119,5/11/2015 13:39:23,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treat,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 13:45:42,1634066116,5/11/2015 13:45:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treat or prevent,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 13:47:03,1634066495,5/11/2015 13:45:51,false,instagc,1.0,29444531,USA,GA,Conyers,184.37.250.198,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treat prevent,N/A,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412965,5/11/2015 13:49:24,1634067356,5/11/2015 13:48:17,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",treat or prevent,n/a,124,58,1,136,98,TWrex-cause,811378-FS1,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES
718412966,5/11/2015 10:04:49,1634002074,5/11/2015 10:04:25,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[SYMPTOM],[SYMPTOM],characterized,N/A,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:13:07,1634004100,5/11/2015 10:11:59,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS) Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",N/A,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:22:50,1634006938,5/11/2015 10:20:03,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],characterized,n/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:23:49,1634007254,5/11/2015 10:23:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:32:12,1634009701,5/11/2015 10:31:21,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,Characterised,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:38:45,1634011506,5/11/2015 10:38:20,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:44:45,1634012983,5/11/2015 10:43:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There's no relation.,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 10:54:41,1634015460,5/11/2015 10:54:09,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],is characterized by,n/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:03:05,1634017709,5/11/2015 11:02:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],characterized by,n/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:27:55,1634023552,5/11/2015 11:25:03,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[MANIFESTATION],[MANIFESTATION],characterized,N/A,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:32:26,1634024775,5/11/2015 11:32:10,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",no,no,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:44:25,1634027710,5/11/2015 11:43:06,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[MANIFESTATION],[MANIFESTATION],"INAPPROPRIATE SINUS TACHYCARDIA is characterized by POSTURAL SINUS TACH<span id=""transmark""></span>YCARDIA",n/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:53:40,1634029966,5/11/2015 11:53:08,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[SYMPTOM],[SYMPTOM],characterized by,N/A,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:55:20,1634030354,5/11/2015 11:54:50,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[MANIFESTATION],[MANIFESTATION],characterized by exaggerated,N/A,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412966,5/11/2015 11:55:19,1634030355,5/11/2015 11:54:16,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",characterized by,N/a,220,14,1,245,45,TWrex-cause,813710-FS1,"Main article: INAPPROPRIATE SINUS TACHYCARDIA [edit] Postural orthostatic tachycardia syndrome (POTS)  Usually in women with no heart problems, this syndrome is characterized by normal resting heart rate but exaggerated POSTURAL SINUS TACHYCARDIA with or without orthostatic hypotension.",POSTURAL SINUS TACHYCARDIA,INAPPROPRIATE SINUS TACHYCARDIA
718412967,5/11/2015 10:00:33,1634000919,5/11/2015 10:00:11,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Addition,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:02:51,1634001501,5/11/2015 10:02:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:12:10,1634003895,5/11/2015 10:10:34,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],fibrinolytic therapy,n/a,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:20:54,1634006412,5/11/2015 10:20:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy for,n/a,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:26:58,1634008177,5/11/2015 10:26:24,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],therapy,Treatment of,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:32:22,1634009749,5/11/2015 10:31:12,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Addition of ASPIRIN and therapy for,n/a,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:34:25,1634010355,5/11/2015 10:32:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:45:19,1634013134,5/11/2015 10:44:47,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],therapy for,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:48:39,1634013883,5/11/2015 10:48:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 10:57:17,1634016133,5/11/2015 10:56:53,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,n/a,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 11:20:55,1634021902,5/11/2015 11:20:25,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],therapy,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 11:24:06,1634022525,5/11/2015 11:23:37,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],therapy for,N/a,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 11:29:37,1634024071,5/11/2015 11:29:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 11:36:02,1634025767,5/11/2015 11:34:39,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"ASPIRIN therapy for MYOCARDIAL INFARCTION WITH S<span id=""transmark""></span>T SEGMENT",I no,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412967,5/11/2015 11:47:00,1634028252,5/11/2015 11:46:20,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[TREATS],[TREATS],therapy,N/A,64,27,-1,100,34,TWrex-cause,804206-FS1,Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION WITH ST SEGMENT elevation.,MYOCARDIAL INFARCTION WITH ST SEGMENT,ASPIRIN
718412968,5/11/2015 10:13:54,1634004397,5/11/2015 10:13:27,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],versus,N/A,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:27:33,1634008315,5/11/2015 10:27:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:29:39,1634008905,5/11/2015 10:28:29,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN,N/A,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:36:01,1634010786,5/11/2015 10:35:19,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],for PAIN,n/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:44:30,1634012885,5/11/2015 10:44:10,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],for,Treats,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:48:40,1634013878,5/11/2015 10:48:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for,n/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:55:06,1634015520,5/11/2015 10:54:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 10:59:56,1634016842,5/11/2015 10:59:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for,n/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 11:19:12,1634021431,5/11/2015 11:18:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],ASPIRIN for,n/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 11:34:57,1634025417,5/11/2015 11:34:25,false,neodev,1.0,20961587,NLD,05,Maastricht,84.26.48.136,[TREATS],[TREATS],versus,N/A,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 11:38:55,1634026374,5/11/2015 11:38:43,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 11:54:51,1634030245,5/11/2015 11:54:18,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[TREATS],[TREATS],"ASPIRIN for POSTPARTUM UTERINE P<span id=""transmark""></span>AIN",na/,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 12:05:58,1634033321,5/11/2015 12:05:44,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[TREATS],[TREATS],for,N/A,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 12:12:42,1634035228,5/11/2015 12:12:17,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[TREATS],[TREATS],for,N/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412968,5/11/2015 12:23:42,1634038618,5/11/2015 12:23:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],for,n/a,74,62,-1,96,69,TWrex-cause,800885-FS1,"Bloomfield SS, Mitchell J, Cissell GB et al. Ketorolac versus ASPIRIN for POSTPARTUM UTERINE PAIN",POSTPARTUM UTERINE PAIN,ASPIRIN
718412969,5/11/2015 12:28:20,1634040120,5/11/2015 12:28:06,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:30:48,1634040792,5/11/2015 12:30:19,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[CAUSES],[CAUSES],caused,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:30:59,1634040829,5/11/2015 12:30:39,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[CAUSES],[CAUSES],caused by,n/a,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:37:31,1634043231,5/11/2015 12:36:29,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.72.201,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],FULMINANT,cdcc,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:40:31,1634044232,5/11/2015 12:39:46,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:42:10,1634044753,5/11/2015 12:41:31,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],FULMINANT YELLOW FEVER,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:42:38,1634044908,5/11/2015 12:42:21,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused,n/a,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:43:27,1634045266,5/11/2015 12:43:16,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[CAUSES],[CAUSES],caused by,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:44:45,1634045629,5/11/2015 12:43:46,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],FULMINANT YELLOW FEVER caused by YELLOW FEVER VIRUS,n/a,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:47:42,1634046516,5/11/2015 12:47:22,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",caused by,caused by,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:49:06,1634046978,5/11/2015 12:48:48,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[CAUSES],[CAUSES],caused by,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 12:54:21,1634048518,5/11/2015 12:53:39,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],FULMINANT YELLOW FEVER caused by YELLOW FEVER VIRUS,na,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 13:38:51,1634063783,5/11/2015 13:37:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused by,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 13:44:13,1634065621,5/11/2015 13:43:14,false,clixsense,1,23144069,GBR,G6,Hull,83.100.235.226,[MANIFESTATION],[MANIFESTATION],caused by,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412969,5/11/2015 13:45:16,1634066016,5/11/2015 13:44:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,56,99,1,77,117,TWrex-cause,812503-FS1,101  Vaccine associated viscerotropic disease resembles FULMINANT YELLOW FEVER caused by wild type YELLOW FEVER VIRUS,FULMINANT YELLOW FEVER,YELLOW FEVER VIRUS
718412970,5/11/2015 14:01:01,1634072516,5/11/2015 14:00:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:01:46,1634072917,5/11/2015 14:01:14,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],appear,n/a,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:04:17,1634074804,5/11/2015 14:03:23,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],clinical features—proximal,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:08:40,1634082374,5/11/2015 14:07:18,false,points4rewards,1.0,28703583,USA,"","",97.73.86.86,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",polydipsia—usually appear in infancy.,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:08:44,1634082461,5/11/2015 14:06:45,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],appear,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:09:13,1634083598,5/11/2015 14:08:46,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],appear,n/a,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:09:33,1634084338,5/11/2015 14:09:06,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SYMPTOM],[SYMPTOM],chief clinical features—proximal,n/a,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:10:03,1634085517,5/11/2015 14:09:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],In HEREDITARY FANCONI SYNDROME POLYURIA appear in infancy.,n/a,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:17:04,1634089992,5/11/2015 14:14:59,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[SYMPTOM],[SYMPTOM],appear in infancy.,n/a,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 14:40:41,1634100294,5/11/2015 14:40:12,false,prodege,1.0,2145087,USA,NY,New York,107.107.63.225,[SYMPTOM],[SYMPTOM],the chief clinical features—proximal,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 15:28:50,1634119895,5/11/2015 15:28:26,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal POLYURIA,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 16:04:00,1634132138,5/11/2015 16:02:57,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[SYMPTOM],[SYMPTOM],clinical,N/A step 2a should be clinical features but it will not allow me to highlight that because it thinks the hyphen is part of the word - defective task,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 16:19:22,1634138631,5/11/2015 16:18:44,false,elite,1.0,30064988,GBR,H3,Leeds,92.22.160.140,[SYMPTOM],[SYMPTOM],chief clinical,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 16:24:10,1634141908,5/11/2015 16:23:31,false,prodege,1.0,22031444,GBR,K6,Portsmouth,89.240.160.95,[MANIFESTATION],[MANIFESTATION],the chief features—proximal,N/a,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412970,5/11/2015 16:25:10,1634142648,5/11/2015 16:24:16,false,instagc,1.0,30475714,USA,OH,Salem,71.74.157.145,[SYMPTOM],[SYMPTOM],chief clinical features—proximal,N/A,125,3,1,132,30,TWrex-cause,813317-FS1,"In HEREDITARY FANCONI SYNDROME the chief clinical features—proximal tubular acidosis, hypophosphatemic rickets, hypokalemia, POLYURIA and polydipsia—usually appear in infancy.",POLYURIA,HEREDITARY FANCONI SYNDROME
718412971,5/11/2015 11:39:36,1634026466,5/11/2015 11:39:27,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.222,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 11:57:04,1634030754,5/11/2015 11:56:08,false,clixsense,1.0,22947672,GBR,"","",88.144.86.217,[IS_A],[IS_A],"IDIOPATHIC PAIN CONDITIONS such as FIBR<span id=""transmark""></span>OMYALGIA",n/a,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:09:30,1634034261,5/11/2015 12:08:59,false,elite,1.0,31856422,GBR,C9,Carlisle,92.18.171.231,[IS_A],[IS_A],such as,N/A,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:14:15,1634035685,5/11/2015 12:13:41,false,getpaid,1.0,31508257,CAN,QC,Gatineau,70.82.102.20,[IS_A],[IS_A],such as,N/a,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:25:29,1634039150,5/11/2015 12:24:58,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],such as,n/a,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:25:34,1634039176,5/11/2015 12:24:47,false,prodege,1.0,12691973,USA,NC,Rocky Mount,76.3.66.226,[SYMPTOM],[SYMPTOM],emerge,N/A,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:27:07,1634039705,5/11/2015 12:26:18,false,clixsense,1.0,24329110,USA,FL,Jacksonville,12.168.136.2,[PART_OF],[PART_OF],overlap with,n/a,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:29:33,1634040418,5/11/2015 12:28:12,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],such as,none,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:32:06,1634041287,5/11/2015 12:31:28,false,neodev,1.0,31726043,USA,DE,"",108.59.10.153,[LOCATION],[LOCATION],generators,dfdsf,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:35:47,1634042693,5/11/2015 12:33:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[PREVENTS],[PREVENTS],FIBROMYALGIA,N/A,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:35:56,1634042739,5/11/2015 12:35:30,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,n/a,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:38:32,1634043571,5/11/2015 12:37:45,false,elite,1.0,32732290,GBR,A7,Birmingham,80.249.56.149,[MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",overlap with,N/A,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:39:29,1634043870,5/11/2015 12:39:11,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],such as,n/a,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:40:00,1634044108,5/11/2015 12:39:44,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[IS_A],[IS_A],such as,N/A,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
718412971,5/11/2015 12:44:02,1634045370,5/11/2015 12:43:27,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.228.242,[IS_A],[IS_A],such as,N/A,126,161,1,151,173,TWrex-cause,814406-FS1,Rationale: • Chronic pelvic pain may emerge from latent pain generators following trauma or stress and can overlap with other IDIOPATHIC PAIN CONDITIONS such as FIBROMYALGIA,IDIOPATHIC PAIN CONDITIONS,FIBROMYALGIA
